SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'TLA'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1BKF_A_FK5A108_1 (FK506 BINDINGPROTEIN) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 7 / 9 | TYR A 147ASP A 158PHE A 166ILE A 172TRP A 175TYR A 198PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 ( 4.6A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNone | 1.10A | 1bkfA-5xb0A:15.4 | 1bkfA-5xb0A:32.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1BKF_A_FK5A108_1 (FK506 BINDINGPROTEIN) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 7 / 9 | TYR A 147ASP A 158VAL A 171ILE A 172TRP A 175TYR A 198PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNone | 0.66A | 1bkfA-5xb0A:15.4 | 1bkfA-5xb0A:32.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1C9H_A_RAPA108_1 (FKBP12.6) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 7 / 12 | TYR A 147ASP A 158PHE A 166ILE A 172TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 ( 4.6A)TLA A 301 (-3.4A)NoneNoneNone | 1.10A | 1c9hA-5xb0A:14.8 | 1c9hA-5xb0A:29.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1C9H_A_RAPA108_1 (FKBP12.6) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 7 / 12 | TYR A 147ASP A 158VAL A 171ILE A 172TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 0.68A | 1c9hA-5xb0A:14.8 | 1c9hA-5xb0A:29.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1EI6_C_PPFC413_1 (PHOSPHONOACETATEHYDROLASE) |
5aho | 5' EXONUCLEASEAPOLLO (Homosapiens) | 4 / 8 | ASP A 145ASP A 120HIS A 31HIS A 276 | None ZN A1320 (-2.5A) ZN A1321 (-3.3A)TLA A1319 ( 3.9A) | 1.00A | 1ei6C-5ahoA:undetectable | 1ei6C-5ahoA:22.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1EI6_C_PPFC413_1 (PHOSPHONOACETATEHYDROLASE) |
5aho | 5' EXONUCLEASEAPOLLO (Homosapiens) | 5 / 8 | ASP A 145THR A 147ASP A 120HIS A 36HIS A 276 | NoneTLA A1319 ( 4.7A) ZN A1320 (-2.5A) ZN A1320 ( 3.4A)TLA A1319 ( 3.9A) | 1.42A | 1ei6C-5ahoA:undetectable | 1ei6C-5ahoA:22.99 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FAP_A_RAPA108_1 (FK506-BINDINGPROTEIN) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 8 / 12 | TYR A 147ASP A 158PHE A 166ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 ( 4.6A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 1.04A | 1fapA-5xb0A:15.6 | 1fapA-5xb0A:32.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FAP_A_RAPA108_1 (FK506-BINDINGPROTEIN) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 8 / 12 | TYR A 147ASP A 158VAL A 171ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 0.66A | 1fapA-5xb0A:15.6 | 1fapA-5xb0A:32.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FAP_A_RAPA108_1 (FK506-BINDINGPROTEIN) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 5 / 12 | TYR A 147VAL A 171TRP A 175ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNone | 0.95A | 1fapA-5xb0A:15.6 | 1fapA-5xb0A:32.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FKB_A_RAPA108_1 (FK506 BINDINGPROTEIN) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 7 / 12 | TYR A 147ASP A 158VAL A 171ILE A 172TRP A 175TYR A 198PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNone | 0.66A | 1fkbA-5xb0A:15.4 | 1fkbA-5xb0A:32.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FKB_A_RAPA108_1 (FK506 BINDINGPROTEIN) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 6 / 12 | TYR A 147PHE A 166ILE A 172TRP A 175TYR A 198PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 ( 4.6A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNone | 1.03A | 1fkbA-5xb0A:15.4 | 1fkbA-5xb0A:32.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FKB_A_RAPA108_1 (FK506 BINDINGPROTEIN) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 5 / 12 | TYR A 147VAL A 171TRP A 175ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNone | 1.04A | 1fkbA-5xb0A:15.4 | 1fkbA-5xb0A:32.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FKF_A_FK5A108_1 (FK506 BINDINGPROTEIN) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 6 / 11 | PHE A 166ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.6A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 1.09A | 1fkfA-5xb0A:15.3 | 1fkfA-5xb0A:32.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FKF_A_FK5A108_1 (FK506 BINDINGPROTEIN) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 8 / 11 | TYR A 147ASP A 158VAL A 171ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 0.63A | 1fkfA-5xb0A:15.3 | 1fkfA-5xb0A:32.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FKJ_A_FK5A108_1 (FK506 BINDINGPROTEIN) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 6 / 11 | PHE A 166ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.6A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 1.09A | 1fkjA-5xb0A:15.3 | 1fkjA-5xb0A:32.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FKJ_A_FK5A108_1 (FK506 BINDINGPROTEIN) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 8 / 11 | TYR A 147ASP A 158VAL A 171ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 0.63A | 1fkjA-5xb0A:15.3 | 1fkjA-5xb0A:32.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FKL_A_RAPA108_1 (FK506 BINDINGPROTEIN) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 8 / 12 | TYR A 147ASP A 158VAL A 171ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 0.70A | 1fklA-5xb0A:15.5 | 1fklA-5xb0A:31.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FKL_A_RAPA108_1 (FK506 BINDINGPROTEIN) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 7 / 12 | TYR A 147PHE A 166ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 ( 4.6A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 1.01A | 1fklA-5xb0A:15.5 | 1fklA-5xb0A:31.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FKL_A_RAPA108_1 (FK506 BINDINGPROTEIN) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 5 / 12 | TYR A 147VAL A 171TRP A 175ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNone | 1.06A | 1fklA-5xb0A:15.5 | 1fklA-5xb0A:31.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1FM6_D_BRLD503_1 (PEROXISOMEPROLIFERATORACTIVATED RECEPTORGAMMA) |
3dme | CONSERVED EXPORTEDPROTEIN (Bordetellapertussis) | 5 / 12 | GLY A 232SER A 48HIS A 52TYR A 248LEU A 256 | FAD A 500 ( 4.6A)FAD A 500 ( 2.9A)TLA A 999 ( 3.7A)TLA A 999 (-4.7A)None | 1.32A | 1fm6D-3dmeA:undetectable | 1fm6D-3dmeA:21.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GTI_F_CCSF47_0 (GLUTATHIONES-TRANSFERASE) |
5um0 | 2,3-BISPHOSPHOGLYCERATE-DEPENDENTPHOSPHOGLYCERATEMUTASE (Neisseriagonorrhoeae) | 4 / 5 | THR A 20LEU A 92GLY A 94LYS A 97 | TLA A 300 (-3.9A)NoneNoneTLA A 300 (-2.9A) | 1.23A | 1gtiF-5um0A:undetectable | 1gtiF-5um0A:19.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GXS_A_BEZA601_0 (P-(S)-HYDROXYMANDELONITRILE LYASE CHAINAP-(S)-HYDROXYMANDELONITRILE LYASE CHAINB) |
5aho | 5' EXONUCLEASEAPOLLO (Homosapiens) | 5 / 7 | GLY A 102PRO A 101ASP A 275SER A 103HIS A 99 | EDO A1316 (-3.4A)NoneTLA A1322 (-4.3A)None ZN A1321 ( 3.4A) | 1.44A | 1gxsA-5ahoA:undetectable1gxsB-5ahoA:1.9 | 1gxsA-5ahoA:20.221gxsB-5ahoA:18.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GXS_C_BEZC602_0 (P-(S)-HYDROXYMANDELONITRILE LYASE CHAINAP-(S)-HYDROXYMANDELONITRILE LYASE CHAINB) |
5aho | 5' EXONUCLEASEAPOLLO (Homosapiens) | 5 / 9 | GLY A 102PRO A 101ASP A 275SER A 103HIS A 99 | EDO A1316 (-3.4A)NoneTLA A1322 (-4.3A)None ZN A1321 ( 3.4A) | 1.41A | 1gxsC-5ahoA:undetectable1gxsD-5ahoA:undetectable | 1gxsC-5ahoA:20.221gxsD-5ahoA:18.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1J36_A_LPRA801_2 (ANGIOTENSINCONVERTING ENZYME) |
5kyv | LUCIFERIN4-MONOOXYGENASE (Photinuspyralis) | 4 / 4 | ARG A 337ALA A 285SER A 284TYR A 255 | NoneNoneTLA A 602 ( 4.8A)None | 1.42A | 1j36A-5kyvA:0.0 | 1j36A-5kyvA:23.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1J36_B_LPRB802_2 (ANGIOTENSINCONVERTING ENZYME) |
5kyv | LUCIFERIN4-MONOOXYGENASE (Photinuspyralis) | 4 / 4 | ARG A 337ALA A 285SER A 284TYR A 255 | NoneNoneTLA A 602 ( 4.8A)None | 1.42A | 1j36B-5kyvA:0.0 | 1j36B-5kyvA:23.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1LII_A_ADNA699_1 (ADENOSINE KINASE) |
2pyx | TRYPTOPHANHALOGENASE (Shewanellafrigidimarina) | 5 / 12 | ILE A 349LEU A 25GLY A 350THR A 21LEU A 374 | NoneNoneTLA A 527 (-3.3A)NoneNone | 0.99A | 1liiA-2pyxA:3.9 | 1liiA-2pyxA:21.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1N4H_A_REAA500_1 (NUCLEAR RECEPTORROR-BETA) |
4auk | RIBOSOMAL RNA LARGESUBUNITMETHYLTRANSFERASE M (Escherichiacoli) | 5 / 11 | ILE A 336ALA A 334ARG A 354LEU A 305ALA A 286 | NoneNoneTLA A1363 (-2.8A)NoneNone | 1.25A | 1n4hA-4aukA:undetectable | 1n4hA-4aukA:21.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1NW5_A_SAMA401_1 (MODIFICATIONMETHYLASE RSRI) |
5aho | 5' EXONUCLEASEAPOLLO (Homosapiens) | 3 / 3 | ASP A 35HIS A 99ASP A 145 | TLA A1319 ( 2.7A) ZN A1321 ( 3.4A)None | 0.85A | 1nw5A-5ahoA:undetectable | 1nw5A-5ahoA:21.47 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1PBK_A_RAPA225_1 (FKBP25) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 8 / 12 | TYR A 147ASP A 158VAL A 171ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 0.70A | 1pbkA-5xb0A:15.2 | 1pbkA-5xb0A:31.03 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1PBK_A_RAPA225_1 (FKBP25) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 6 / 12 | VAL A 171ILE A 172TRP A 175ALA A 203ILE A 207PHE A 215 | TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 1.23A | 1pbkA-5xb0A:15.2 | 1pbkA-5xb0A:31.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1PKV_A_RBFA100_1 (RIBOFLAVIN SYNTHASEALPHA CHAIN) |
2jfw | GLUTAMATE RACEMASE (Enterococcusfaecium) | 5 / 11 | CYH A 77ILE A 97THR A 215ILE A 75VAL A 74 | TLA A1272 ( 4.2A)NoneNoneNoneNone | 1.20A | 1pkvA-2jfwA:undetectable1pkvB-2jfwA:undetectable | 1pkvA-2jfwA:17.531pkvB-2jfwA:17.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1PKV_B_RBFB101_1 (RIBOFLAVIN SYNTHASEALPHA CHAIN) |
2jfw | GLUTAMATE RACEMASE (Enterococcusfaecium) | 5 / 11 | ILE A 75VAL A 74CYH A 77ILE A 97THR A 215 | NoneNoneTLA A1272 ( 4.2A)NoneNone | 1.15A | 1pkvA-2jfwA:undetectable1pkvB-2jfwA:undetectable | 1pkvA-2jfwA:17.531pkvB-2jfwA:17.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1Q0Y_H_MOIH401_1 (FAB 9B1, HEAVY CHAINFAB 9B1, LIGHT CHAIN) |
5mux | 2-METHYLCITRATEDEHYDRATASE (Bacillussubtilis) | 4 / 7 | GLU A 282ILE A 321TRP A 102LEU A 98 | TLA A 501 (-3.4A)NoneNoneNone | 1.36A | 1q0yH-5muxA:undetectable1q0yL-5muxA:undetectable | 1q0yH-5muxA:20.881q0yL-5muxA:17.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1Q13_A_TESA501_1 (PROSTAGLANDIN-E29-REDUCTASE) |
3ekg | MANDELATERACEMASE/MUCONATELACTONIZING ENZYME (Azotobactervinelandii) | 4 / 6 | TYR A 23HIS A 320GLU A 362PRO A 363 | NoneTLA A 501 (-4.3A)NoneNone | 1.39A | 1q13A-3ekgA:5.5 | 1q13A-3ekgA:21.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1Q6I_A_FK5A301_1 (FKBP-TYPEPEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKPA) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 8 / 9 | TYR A 147ASP A 158VAL A 171ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 0.67A | 1q6iA-5xb0A:20.7 | 1q6iA-5xb0A:28.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1Q6I_B_FK5B401_1 (FKBP-TYPEPEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKPA) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 8 / 10 | TYR A 147ASP A 158VAL A 171ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 0.58A | 1q6iB-5xb0A:20.5 | 1q6iB-5xb0A:28.89 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1TCO_C_FK5C509_2 (FK506-BINDINGPROTEIN) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 7 / 11 | PHE A 166VAL A 171ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.6A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 1.07A | 1tcoC-5xb0A:15.0 | 1tcoC-5xb0A:32.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1TCO_C_FK5C509_2 (FK506-BINDINGPROTEIN) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 8 / 11 | TYR A 147ASP A 158VAL A 171ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 0.77A | 1tcoC-5xb0A:15.0 | 1tcoC-5xb0A:32.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1V7Z_A_CRNA401_1 (CREATININEAMIDOHYDROLASE) |
5kds | F5/8 TYPE C DOMAINPROTEIN (Clostridiumperfringens) | 4 / 8 | GLU A 771HIS A 756HIS A 760GLU A 757 | TLA A1102 ( 2.5A) ZN A1101 (-3.3A) ZN A1101 ( 3.3A) ZN A1101 ( 4.3A) | 0.78A | 1v7zA-5kdsA:undetectable | 1v7zA-5kdsA:18.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1V7Z_B_CRNB3401_1 (CREATININEAMIDOHYDROLASE) |
5kds | F5/8 TYPE C DOMAINPROTEIN (Clostridiumperfringens) | 4 / 8 | GLU A 771HIS A 756HIS A 760GLU A 757 | TLA A1102 ( 2.5A) ZN A1101 (-3.3A) ZN A1101 ( 3.3A) ZN A1101 ( 4.3A) | 0.79A | 1v7zB-5kdsA:undetectable | 1v7zB-5kdsA:18.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1V7Z_C_CRNC4401_1 (CREATININEAMIDOHYDROLASE) |
5kds | F5/8 TYPE C DOMAINPROTEIN (Clostridiumperfringens) | 4 / 8 | GLU A 771HIS A 756HIS A 760GLU A 757 | TLA A1102 ( 2.5A) ZN A1101 (-3.3A) ZN A1101 ( 3.3A) ZN A1101 ( 4.3A) | 0.79A | 1v7zC-5kdsA:undetectable | 1v7zC-5kdsA:18.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1V7Z_D_CRND5401_1 (CREATININEAMIDOHYDROLASE) |
5kds | F5/8 TYPE C DOMAINPROTEIN (Clostridiumperfringens) | 4 / 8 | GLU A 771HIS A 756HIS A 760GLU A 757 | TLA A1102 ( 2.5A) ZN A1101 (-3.3A) ZN A1101 ( 3.3A) ZN A1101 ( 4.3A) | 0.81A | 1v7zD-5kdsA:undetectable | 1v7zD-5kdsA:18.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1V7Z_E_CRNE6401_1 (CREATININEAMIDOHYDROLASE) |
5kds | F5/8 TYPE C DOMAINPROTEIN (Clostridiumperfringens) | 4 / 8 | GLU A 771HIS A 756HIS A 760GLU A 757 | TLA A1102 ( 2.5A) ZN A1101 (-3.3A) ZN A1101 ( 3.3A) ZN A1101 ( 4.3A) | 0.81A | 1v7zE-5kdsA:undetectable | 1v7zE-5kdsA:18.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1V7Z_F_CRNF7401_1 (CREATININEAMIDOHYDROLASE) |
5kds | F5/8 TYPE C DOMAINPROTEIN (Clostridiumperfringens) | 4 / 8 | GLU A 771HIS A 756HIS A 760GLU A 757 | TLA A1102 ( 2.5A) ZN A1101 (-3.3A) ZN A1101 ( 3.3A) ZN A1101 ( 4.3A) | 0.80A | 1v7zF-5kdsA:undetectable | 1v7zF-5kdsA:18.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1X8V_A_ESLA471_1 (CYTOCHROME P450 51) |
5unc | PHOSPHOENOLPYRUVATEPHOSPHOMUTASE (Streptomycesplatensis) | 4 / 8 | TYR A 231PHE A 137ALA A 250HIS A 252 | NoneNoneTLA A 401 (-3.5A)None | 1.02A | 1x8vA-5uncA:undetectable | 1x8vA-5uncA:23.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YAJ_F_BEZF5023_0 (CES1 PROTEIN) |
2egz | 3-DEHYDROQUINATEDEHYDRATASE (Aquifexaeolicus) | 4 / 6 | LEU A 157GLY A 183SER A 188ILE A 170 | NoneNoneNoneTLA A4988 (-3.8A) | 0.97A | 1yajF-2egzA:undetectable | 1yajF-2egzA:19.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YAT_A_FK5A108_1 (FK506 BINDINGPROTEIN) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 7 / 11 | PHE A 166VAL A 171ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.6A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 1.01A | 1yatA-5xb0A:17.5 | 1yatA-5xb0A:32.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YAT_A_FK5A108_1 (FK506 BINDINGPROTEIN) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 8 / 11 | TYR A 147ASP A 158VAL A 171ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 0.65A | 1yatA-5xb0A:17.5 | 1yatA-5xb0A:32.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ZGY_A_BRLA503_1 (PEROXISOMEPROLIFERATORACTIVATED RECEPTORGAMMA) |
3dme | CONSERVED EXPORTEDPROTEIN (Bordetellapertussis) | 5 / 12 | GLY A 232SER A 48HIS A 52TYR A 248LEU A 256 | FAD A 500 ( 4.6A)FAD A 500 ( 2.9A)TLA A 999 ( 3.7A)TLA A 999 (-4.7A)None | 1.25A | 1zgyA-3dmeA:undetectable | 1zgyA-3dmeA:21.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2AYL_A_FLPA1701_1 (PROSTAGLANDIN G/HSYNTHASE 1) |
3a3u | MENAQUINONEBIOSYNTHETIC ENZYME (Thermusthermophilus) | 5 / 12 | VAL A 250LEU A 253LEU A 270GLY A 177ALA A 178 | NoneNoneNoneTLA A 401 ( 4.4A)None | 1.01A | 2aylA-3a3uA:undetectable | 2aylA-3a3uA:19.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2AYL_B_FLPB2701_1 (PROSTAGLANDIN G/HSYNTHASE 1) |
3a3u | MENAQUINONEBIOSYNTHETIC ENZYME (Thermusthermophilus) | 5 / 12 | VAL A 250LEU A 253LEU A 270GLY A 177ALA A 178 | NoneNoneNoneTLA A 401 ( 4.4A)None | 1.01A | 2aylB-3a3uA:undetectable | 2aylB-3a3uA:19.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2C49_B_ADNB1301_1 (SUGAR KINASE MJ0406) |
3os7 | GALACTOSEMUTAROTASE-LIKEPROTEIN (Clostridiumacetobutylicum) | 4 / 7 | HIS A 184ALA A 186GLY A 72ASN A 38 | TLA A 401 (-3.9A)NoneNoneNone | 0.75A | 2c49B-3os7A:undetectable | 2c49B-3os7A:22.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2DG3_A_RAPA501_1 (FK506-BINDINGPROTEIN 1A) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 7 / 11 | TYR A 147ASP A 158PHE A 166ILE A 172TRP A 175TYR A 198PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 ( 4.6A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNone | 1.11A | 2dg3A-5xb0A:15.2 | 2dg3A-5xb0A:32.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2DG3_A_RAPA501_1 (FK506-BINDINGPROTEIN 1A) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 7 / 11 | TYR A 147ASP A 158VAL A 171ILE A 172TRP A 175TYR A 198PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNone | 0.67A | 2dg3A-5xb0A:15.2 | 2dg3A-5xb0A:32.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2DG3_A_RAPA501_1 (FK506-BINDINGPROTEIN 1A) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 5 / 11 | TYR A 147ASP A 158VAL A 171TRP A 175ILE A 207 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)None | 1.34A | 2dg3A-5xb0A:15.2 | 2dg3A-5xb0A:32.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2DG4_A_RAPA501_1 (FK506-BINDINGPROTEIN 1A) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 6 / 11 | TYR A 147ASP A 158VAL A 171ILE A 172TYR A 198PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNone | 0.70A | 2dg4A-5xb0A:14.9 | 2dg4A-5xb0A:31.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2DG9_A_RAPA501_1 (FK506-BINDINGPROTEIN 1A) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 6 / 11 | TYR A 147ASP A 158PHE A 166ILE A 172TYR A 198PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 ( 4.6A)TLA A 301 (-3.4A)NoneNone | 1.18A | 2dg9A-5xb0A:15.0 | 2dg9A-5xb0A:31.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2DG9_A_RAPA501_1 (FK506-BINDINGPROTEIN 1A) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 6 / 11 | TYR A 147ASP A 158VAL A 171ILE A 172TYR A 198PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNone | 0.72A | 2dg9A-5xb0A:15.0 | 2dg9A-5xb0A:31.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2F9W_A_PAUA6002_0 (PANTOTHENATE KINASE) |
4mrq | PHOSPHOMANNOMUTASE/PHOSPHOGLUCOMUTASE (Pseudomonasaeruginosa) | 4 / 8 | ARG A 15GLY A 21THR A 31ILE A 35 | TLA A 502 (-4.1A)NoneNoneNone | 0.93A | 2f9wA-4mrqA:undetectable2f9wB-4mrqA:undetectable | 2f9wA-4mrqA:21.432f9wB-4mrqA:21.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2FKE_A_FK5A108_1 (FK506 BINDINGPROTEIN) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 6 / 11 | PHE A 166ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.6A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 1.09A | 2fkeA-5xb0A:15.4 | 2fkeA-5xb0A:32.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2FKE_A_FK5A108_1 (FK506 BINDINGPROTEIN) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 8 / 11 | TYR A 147ASP A 158VAL A 171ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 0.62A | 2fkeA-5xb0A:15.4 | 2fkeA-5xb0A:32.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2J2P_C_SC2C1289_1 (FICOLIN-2) |
5unc | PHOSPHOENOLPYRUVATEPHOSPHOMUTASE (Streptomycesplatensis) | 4 / 6 | ASP A 100SER A 64LEU A 61GLY A 60 | NoneNoneTLA A 401 (-4.0A)TLA A 401 ( 4.0A) | 0.94A | 2j2pA-5uncA:undetectable2j2pC-5uncA:undetectable | 2j2pA-5uncA:20.172j2pC-5uncA:20.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2J2P_F_SC2F1289_1 (FICOLIN-2) |
5unc | PHOSPHOENOLPYRUVATEPHOSPHOMUTASE (Streptomycesplatensis) | 4 / 6 | ASP A 100SER A 64LEU A 61GLY A 60 | NoneNoneTLA A 401 (-4.0A)TLA A 401 ( 4.0A) | 0.96A | 2j2pD-5uncA:undetectable2j2pF-5uncA:undetectable | 2j2pD-5uncA:20.172j2pF-5uncA:20.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2JJ8_C_AZZC1211_1 (DEOXYNUCLEOSIDEKINASE) |
3mwe | ATP-CITRATE SYNTHASE (Homosapiens) | 5 / 12 | ILE A 414LEU A 388MET A 391PHE A 354ALA A 280 | NoneNoneNoneNoneTLA A 427 ( 4.2A) | 0.83A | 2jj8C-3mweA:undetectable | 2jj8C-3mweA:19.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Q0J_B_BEZB500_0 (QUINOLONE SIGNALRESPONSE PROTEIN) |
5aho | 5' EXONUCLEASEAPOLLO (Homosapiens) | 5 / 11 | HIS A 31HIS A 276ASP A 120HIS A 36SER A 0 | ZN A1321 (-3.3A)TLA A1319 ( 3.9A) ZN A1320 (-2.5A) ZN A1320 ( 3.4A)None | 1.21A | 2q0jB-5ahoA:7.4 | 2q0jB-5ahoA:21.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2QHF_A_ACTA504_0 (CHORISMATE SYNTHASE) |
4it1 | PUTATIVE GLUCARATEDEHYDRATASE (Pseudomonasfluorescens) | 4 / 5 | SER A 323HIS A 349ARG A 404LEU A 18 | TLA A 502 ( 4.9A)TLA A 502 (-4.7A)TLA A 502 (-2.9A)None | 1.41A | 2qhfA-4it1A:undetectable | 2qhfA-4it1A:23.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2QL8_B_BEZB143_0 (PUTATIVE REDOXPROTEIN) |
3mwe | ATP-CITRATE SYNTHASE (Homosapiens) | 4 / 6 | TYR A 307THR A 348ALA A 345PRO A 311 | NoneTLA A 427 (-3.7A)TLA A 427 (-3.6A)None | 1.22A | 2ql8A-3mweA:undetectable2ql8B-3mweA:undetectable | 2ql8A-3mweA:16.712ql8B-3mweA:16.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2VCD_A_RAPA138_1 (OUTER MEMBRANEPROTEIN MIP) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 8 / 11 | TYR A 147PHE A 157ASP A 158PHE A 166VAL A 171ILE A 172TRP A 175TYR A 198 | TLA A 301 ( 4.4A)NoneTLA A 301 (-3.7A)TLA A 301 ( 4.6A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)None | 1.01A | 2vcdA-5xb0A:19.0 | 2vcdA-5xb0A:40.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2VN1_A_FK5A501_1 (70 KDAPEPTIDYLPROLYLISOMERASE) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 6 / 11 | PHE A 157PHE A 166TRP A 175TYR A 198ILE A 207PHE A 215 | NoneTLA A 301 ( 4.6A)TLA A 301 (-3.4A)NoneNoneNone | 1.23A | 2vn1A-5xb0A:16.2 | 2vn1A-5xb0A:35.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2VN1_A_FK5A501_1 (70 KDAPEPTIDYLPROLYLISOMERASE) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 8 / 11 | TYR A 147PHE A 157ASP A 158VAL A 171TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)NoneTLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 0.87A | 2vn1A-5xb0A:16.2 | 2vn1A-5xb0A:35.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2VN1_B_FK5B501_1 (70 KDAPEPTIDYLPROLYLISOMERASE) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 5 / 10 | PHE A 166ILE A 172TRP A 175TYR A 198PHE A 215 | TLA A 301 ( 4.6A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNone | 1.13A | 2vn1B-5xb0A:16.2 | 2vn1B-5xb0A:35.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2VN1_B_FK5B501_1 (70 KDAPEPTIDYLPROLYLISOMERASE) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 7 / 10 | TYR A 147ASP A 158VAL A 171ILE A 172TRP A 175TYR A 198PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNone | 0.76A | 2vn1B-5xb0A:16.2 | 2vn1B-5xb0A:35.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2VQY_A_PARA1201_1 (AAC(6')-IB) |
5unc | PHOSPHOENOLPYRUVATEPHOSPHOMUTASE (Streptomycesplatensis) | 5 / 12 | GLY A 102TYR A 116ASP A 98ASP A 71ASP A 73 | NoneNoneTLA A 401 (-3.3A)TLA A 401 (-3.1A)None | 1.38A | 2vqyA-5uncA:undetectable | 2vqyA-5uncA:20.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2X7H_B_PFNB1374_1 (ZINC-BINDING ALCOHOLDEHYDROGENASEDOMAIN-CONTAININGPROTEIN 2) |
3dme | CONSERVED EXPORTEDPROTEIN (Bordetellapertussis) | 4 / 4 | TYR A 248LEU A 260LEU A 246HIS A 52 | TLA A 999 (-4.7A)NoneNoneTLA A 999 ( 3.7A) | 1.34A | 2x7hB-3dmeA:2.7 | 2x7hB-3dmeA:22.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2X9G_A_LYAA1270_2 (PTERIDINE REDUCTASE) |
3os7 | GALACTOSEMUTAROTASE-LIKEPROTEIN (Clostridiumacetobutylicum) | 3 / 3 | MET A 291VAL A 202GLU A 300 | NoneNoneTLA A 401 ( 4.7A) | 0.91A | 2x9gA-3os7A:undetectable | 2x9gA-3os7A:20.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Y00_B_Y00B601_2 (BETA-1 ADRENERGICRECEPTOR) |
3os7 | GALACTOSEMUTAROTASE-LIKEPROTEIN (Clostridiumacetobutylicum) | 3 / 3 | VAL A 189ASN A 289TRP A 288 | NoneNoneTLA A 401 (-4.4A) | 1.10A | 2y00B-3os7A:undetectable | 2y00B-3os7A:20.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2YQZ_B_SAMB401_0 (HYPOTHETICAL PROTEINTTHA0223) |
1nxj | PROBABLES-ADENOSYLMETHIONINE:2-DEMETHYLMENAQUINONE METHYLTRANSFERASE (Mycobacteriumtuberculosis) | 6 / 12 | GLY A 92GLY A 62ILE A 39VAL A 65LEU A 93VAL A 77 | NoneNoneNoneNoneNoneTLA A 391 ( 4.8A) | 1.45A | 2yqzB-1nxjA:undetectable | 2yqzB-1nxjA:23.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3A6J_A_CRNA303_1 (CREATININEAMIDOHYDROLASE) |
5kds | F5/8 TYPE C DOMAINPROTEIN (Clostridiumperfringens) | 4 / 8 | GLU A 771HIS A 756HIS A 760GLU A 757 | TLA A1102 ( 2.5A) ZN A1101 (-3.3A) ZN A1101 ( 3.3A) ZN A1101 ( 4.3A) | 0.78A | 3a6jA-5kdsA:undetectable | 3a6jA-5kdsA:18.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3A6J_B_CRNB304_1 (CREATININEAMIDOHYDROLASE) |
5kds | F5/8 TYPE C DOMAINPROTEIN (Clostridiumperfringens) | 4 / 7 | GLU A 771HIS A 756HIS A 760GLU A 757 | TLA A1102 ( 2.5A) ZN A1101 (-3.3A) ZN A1101 ( 3.3A) ZN A1101 ( 4.3A) | 0.76A | 3a6jB-5kdsA:undetectable | 3a6jB-5kdsA:18.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3A6J_C_CRNC305_1 (CREATININEAMIDOHYDROLASE) |
5kds | F5/8 TYPE C DOMAINPROTEIN (Clostridiumperfringens) | 4 / 8 | GLU A 771HIS A 756HIS A 760GLU A 757 | TLA A1102 ( 2.5A) ZN A1101 (-3.3A) ZN A1101 ( 3.3A) ZN A1101 ( 4.3A) | 0.76A | 3a6jC-5kdsA:undetectable | 3a6jC-5kdsA:18.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3A6J_E_CRNE306_1 (CREATININEAMIDOHYDROLASE) |
5kds | F5/8 TYPE C DOMAINPROTEIN (Clostridiumperfringens) | 4 / 8 | GLU A 771HIS A 756HIS A 760GLU A 757 | TLA A1102 ( 2.5A) ZN A1101 (-3.3A) ZN A1101 ( 3.3A) ZN A1101 ( 4.3A) | 0.80A | 3a6jE-5kdsA:undetectable | 3a6jE-5kdsA:18.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3A6J_F_CRNF307_1 (CREATININEAMIDOHYDROLASE) |
5kds | F5/8 TYPE C DOMAINPROTEIN (Clostridiumperfringens) | 4 / 8 | GLU A 771HIS A 756HIS A 760GLU A 757 | TLA A1102 ( 2.5A) ZN A1101 (-3.3A) ZN A1101 ( 3.3A) ZN A1101 ( 4.3A) | 0.75A | 3a6jF-5kdsA:undetectable | 3a6jF-5kdsA:18.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3C0Z_A_SHHA301_1 (HISTONE DEACETYLASE7A) |
3it7 | PROTEASE LASA (Pseudomonasaeruginosa) | 4 / 5 | HIS A 120HIS A 81ASP A 36HIS A 122 | TLA A 300 (-3.9A)TLA A 300 (-4.2A) ZN A 183 ( 2.1A) ZN A 183 ( 3.0A) | 1.03A | 3c0zA-3it7A:undetectable | 3c0zA-3it7A:16.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3C0Z_C_SHHC301_1 (HISTONE DEACETYLASE7A) |
3it7 | PROTEASE LASA (Pseudomonasaeruginosa) | 4 / 6 | HIS A 120HIS A 81ASP A 36HIS A 122 | TLA A 300 (-3.9A)TLA A 300 (-4.2A) ZN A 183 ( 2.1A) ZN A 183 ( 3.0A) | 1.04A | 3c0zC-3it7A:undetectable | 3c0zC-3it7A:16.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3CYX_A_ROCA201_4 (HIV-1 PROTEASE) |
5aho | 5' EXONUCLEASEAPOLLO (Homosapiens) | 4 / 4 | LEU A 144ASP A 14VAL A 298THR A 147 | NoneNoneNoneTLA A1319 ( 4.7A) | 1.29A | 3cyxB-5ahoA:undetectable | 3cyxB-5ahoA:13.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3DTU_C_DXCC576_0 (CYTOCHROME C OXIDASESUBUNIT 1CYTOCHROME C OXIDASESUBUNIT 2) |
5mux | 2-METHYLCITRATEDEHYDRATASE (Bacillussubtilis) | 4 / 8 | ALA A 289ALA A 292ILE A 340GLU A 282 | NoneNoneNoneTLA A 501 (-3.4A) | 0.85A | 3dtuC-5muxA:0.03dtuD-5muxA:undetectable | 3dtuC-5muxA:undetectable3dtuD-5muxA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3DZG_B_NCAB302_0 (ADP-RIBOSYL CYCLASE1) |
4gr5 | NON-RIBOSOMALPEPTIDE SYNTHETASE (Streptomyceslydicus) | 4 / 7 | LEU A 416ASP A 434SER A 361THR A 365 | TLA A 602 (-4.6A)NoneNoneNone | 0.98A | 3dzgB-4gr5A:2.4 | 3dzgB-4gr5A:17.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3IHZ_A_FK5A501_1 (70 KDAPEPTIDYLPROLYLISOMERASE, PUTATIVE) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 7 / 10 | PHE A 166VAL A 171ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.6A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 1.03A | 3ihzA-5xb0A:16.0 | 3ihzA-5xb0A:31.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3IHZ_A_FK5A501_1 (70 KDAPEPTIDYLPROLYLISOMERASE, PUTATIVE) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 8 / 10 | TYR A 147ASP A 158VAL A 171ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 0.67A | 3ihzA-5xb0A:16.0 | 3ihzA-5xb0A:31.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3IHZ_A_FK5A501_2 (70 KDAPEPTIDYLPROLYLISOMERASE, PUTATIVE) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 5 / 8 | ASP A 158PHE A 166TRP A 175TYR A 198ILE A 207 | TLA A 301 (-3.7A)TLA A 301 ( 4.6A)TLA A 301 (-3.4A)NoneNone | 1.23A | 3ihzB-5xb0A:16.4 | 3ihzB-5xb0A:31.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3IHZ_A_FK5A501_2 (70 KDAPEPTIDYLPROLYLISOMERASE, PUTATIVE) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 5 / 8 | TYR A 147ASP A 158TRP A 175TYR A 198ILE A 207 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)NoneNone | 0.64A | 3ihzB-5xb0A:16.4 | 3ihzB-5xb0A:31.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3IV6_A_SAMA301_1 (PUTATIVEZN-DEPENDENT ALCOHOLDEHYDROGENASE) |
2pyx | TRYPTOPHANHALOGENASE (Shewanellafrigidimarina) | 3 / 3 | SER A 301ASP A 253ASP A 424 | NoneTLA A 528 (-4.1A)None | 0.86A | 3iv6A-2pyxA:3.3 | 3iv6A-2pyxA:19.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3IV6_C_SAMC301_1 (PUTATIVEZN-DEPENDENT ALCOHOLDEHYDROGENASE) |
2pyx | TRYPTOPHANHALOGENASE (Shewanellafrigidimarina) | 3 / 3 | SER A 301ASP A 253ASP A 424 | NoneTLA A 528 (-4.1A)None | 0.86A | 3iv6C-2pyxA:undetectable | 3iv6C-2pyxA:19.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3K4V_D_ROCD201_2 (HIV-1 PROTEASE) |
6frl | TRYPTOPHANHALOGENASESUPERFAMILY (Brevundimonassp.BAL3) | 4 / 4 | GLY A 230ASP A 220GLY A 339THR A 384 | NoneNoneTLA A 601 (-3.5A)None | 1.10A | 3k4vC-6frlA:undetectable | 3k4vC-6frlA:21.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KK6_A_CELA701_1 (PROSTAGLANDIN G/HSYNTHASE 1) |
3a3u | MENAQUINONEBIOSYNTHETIC ENZYME (Thermusthermophilus) | 5 / 12 | VAL A 250LEU A 253LEU A 270GLY A 177ALA A 178 | NoneNoneNoneTLA A 401 ( 4.4A)None | 1.04A | 3kk6A-3a3uA:undetectable | 3kk6A-3a3uA:19.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KU9_B_SPMB700_1 (POLYAMINE OXIDASE) |
4ryk | LMO0325 PROTEIN (Listeriamonocytogenes) | 4 / 7 | GLU A 185GLU A 226TYR A 189TYR A 184 | NoneNoneTLA A 402 (-3.6A)None | 1.04A | 3ku9B-4rykA:undetectable | 3ku9B-4rykA:18.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3KZ7_A_RAPA225_1 (FK506-BINDINGPROTEIN 3) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 8 / 10 | TYR A 147ASP A 158VAL A 171ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 0.69A | 3kz7A-5xb0A:14.8 | 3kz7A-5xb0A:33.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3LSL_A_PZIA800_0 (GLUTAMATE RECEPTOR 2) |
5hyh | UNCHARACTERIZEDPROTEIN (Streptomycesvenezuelae) | 4 / 7 | TYR A 101ASN A 233LEU A 212ASP A 213 | NoneNoneNoneTLA A 403 (-3.2A) | 1.24A | 3lslA-5hyhA:undetectable3lslD-5hyhA:undetectable | 3lslA-5hyhA:23.443lslD-5hyhA:23.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3LSL_A_PZIA802_0 (GLUTAMATE RECEPTOR 2) |
2pyx | TRYPTOPHANHALOGENASE (Shewanellafrigidimarina) | 3 / 3 | ASP A 253ASN A 334SER A 301 | TLA A 528 (-4.1A)TLA A 528 (-4.1A)None | 0.95A | 3lslA-2pyxA:undetectable3lslD-2pyxA:undetectable | 3lslA-2pyxA:19.483lslD-2pyxA:19.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3LSL_D_PZID800_0 (GLUTAMATE RECEPTOR 2) |
5hyh | UNCHARACTERIZEDPROTEIN (Streptomycesvenezuelae) | 4 / 7 | TYR A 101ASN A 233LEU A 212ASP A 213 | NoneNoneNoneTLA A 403 (-3.2A) | 1.19A | 3lslA-5hyhA:undetectable3lslD-5hyhA:undetectable | 3lslA-5hyhA:23.443lslD-5hyhA:23.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3LSL_D_PZID802_0 (GLUTAMATE RECEPTOR 2) |
2pyx | TRYPTOPHANHALOGENASE (Shewanellafrigidimarina) | 3 / 3 | SER A 301ASP A 253ASN A 334 | NoneTLA A 528 (-4.1A)TLA A 528 (-4.1A) | 0.96A | 3lslA-2pyxA:undetectable3lslD-2pyxA:undetectable | 3lslA-2pyxA:19.483lslD-2pyxA:19.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3LSL_G_PZIG800_0 (GLUTAMATE RECEPTOR 2) |
5hyh | UNCHARACTERIZEDPROTEIN (Streptomycesvenezuelae) | 4 / 6 | TYR A 101ASN A 233LEU A 212ASP A 213 | NoneNoneNoneTLA A 403 (-3.2A) | 1.20A | 3lslG-5hyhA:undetectable | 3lslG-5hyhA:23.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3LSL_G_PZIG801_0 (GLUTAMATE RECEPTOR 2) |
3p1t | PUTATIVEHISTIDINOL-PHOSPHATEAMINOTRANSFERASE (Burkholderiapseudomallei) | 3 / 3 | PRO A 143SER A 274ASN A 145 | NoneNoneTLA A 343 (-3.3A) | 0.81A | 3lslG-3p1tA:undetectable | 3lslG-3p1tA:20.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3MDR_B_GJZB506_1 (CHOLESTEROL24-HYDROXYLASE) |
2pyx | TRYPTOPHANHALOGENASE (Shewanellafrigidimarina) | 4 / 6 | ILE A 347ALA A 348ALA A 17THR A 21 | NoneNoneTLA A 527 (-3.3A)None | 0.98A | 3mdrB-2pyxA:undetectable | 3mdrB-2pyxA:22.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) |
3ekg | MANDELATERACEMASE/MUCONATELACTONIZING ENZYME (Azotobactervinelandii) | 5 / 12 | GLY A 19GLN A 358MET A 344LEU A 342ILE A 55 | NoneNoneNoneTLA A 501 (-4.1A)None | 1.34A | 3mnoA-3ekgA:undetectable | 3mnoA-3ekgA:20.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) |
3ekg | MANDELATERACEMASE/MUCONATELACTONIZING ENZYME (Azotobactervinelandii) | 5 / 12 | GLY A 19GLN A 358MET A 344LEU A 342ILE A 55 | NoneNoneNoneTLA A 501 (-4.1A)None | 1.36A | 3mnpA-3ekgA:undetectable | 3mnpA-3ekgA:20.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3NS1_C_PM6C1_1 (XANTHINEDEHYDROGENASE/OXIDASE) |
3a3u | MENAQUINONEBIOSYNTHETIC ENZYME (Thermusthermophilus) | 4 / 6 | PHE A 254THR A 107ALA A 263ALA A 257 | NoneTLA A 401 (-3.9A)NoneNone | 1.06A | 3ns1C-3a3uA:undetectable | 3ns1C-3a3uA:17.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3NV6_A_CAMA422_0 (CYTOCHROME P450) |
1vpd | TARTRONATESEMIALDEHYDEREDUCTASE (Salmonellaenterica) | 3 / 3 | GLY A 124ILE A 178VAL A 179 | TLA A 501 (-3.6A)NoneTLA A 501 ( 4.7A) | 0.50A | 3nv6A-1vpdA:undetectable | 3nv6A-1vpdA:22.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3O5R_A_FK5A1001_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 7 / 11 | PHE A 166VAL A 171ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.6A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 1.05A | 3o5rA-5xb0A:16.3 | 3o5rA-5xb0A:31.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3O5R_A_FK5A1001_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 8 / 11 | TYR A 147ASP A 158VAL A 171ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 0.69A | 3o5rA-5xb0A:16.3 | 3o5rA-5xb0A:31.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3O9M_B_BEZB999_0 (CHOLINESTERASE) |
1zl0 | HYPOTHETICAL PROTEINPA5198 (Pseudomonasaeruginosa) | 4 / 6 | GLY A 87GLY A 88SER A 115HIS A 285 | EDO A1407 (-3.5A)EDO A1408 ( 3.4A)TLA A1401 ( 2.0A)EDO A1407 ( 3.9A) | 0.75A | 3o9mB-1zl0A:undetectable | 3o9mB-1zl0A:20.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OXV_A_478A200_1 (HIV-1 PROTEASE) |
4gr5 | NON-RIBOSOMALPEPTIDE SYNTHETASE (Streptomyceslydicus) | 4 / 6 | GLU A 442PRO A 60ARG A 443GLY A 441 | TLA A 602 ( 4.3A)NoneTLA A 602 (-4.3A)None | 1.37A | 3oxvA-4gr5A:undetectable | 3oxvA-4gr5A:9.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OZW_B_KKKB413_1 (FLAVOHEMOGLOBIN) |
4it1 | PUTATIVE GLUCARATEDEHYDRATASE (Pseudomonasfluorescens) | 5 / 12 | ILE A 174GLN A 177HIS A 25ILE A 367PRO A 351 | NoneNoneTLA A 502 (-4.1A)NoneNone | 1.08A | 3ozwB-4it1A:undetectable | 3ozwB-4it1A:25.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P5N_A_RBFA190_1 (RIBOFLAVIN UPTAKEPROTEIN) |
3a3u | MENAQUINONEBIOSYNTHETIC ENZYME (Thermusthermophilus) | 5 / 12 | ASP A 161GLY A 82ALA A 76LEU A 84ASN A 13 | NoneNoneTLA A 401 ( 4.8A)NoneNone | 1.17A | 3p5nA-3a3uA:undetectable | 3p5nA-3a3uA:21.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3PFG_A_SAMA264_1 (N-METHYLTRANSFERASE) |
5unc | PHOSPHOENOLPYRUVATEPHOSPHOMUTASE (Streptomycesplatensis) | 3 / 3 | TYR A 103TYR A 116GLU A 127 | NoneNoneTLA A 401 ( 4.6A) | 0.92A | 3pfgA-5uncA:2.6 | 3pfgA-5uncA:23.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3PWW_A_ROCA1001_2 (ENDOTHIAPEPSIN) |
3i16 | ALUMINUM RESISTANCEPROTEIN (Clostridiumnovyi) | 4 / 8 | SER A 184SER A 387ASP A 217THR A 100 | NoneTLA A 427 ( 4.9A)NoneTLA A 427 (-3.8A) | 0.77A | 3pwwA-3i16A:undetectable | 3pwwA-3i16A:24.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3R2J_C_NIOC311_1 (ALPHA/BETA-HYDROLASE-LIKE PROTEIN) |
4mrq | PHOSPHOMANNOMUTASE/PHOSPHOGLUCOMUTASE (Pseudomonasaeruginosa) | 5 / 12 | ASP A 244ASP A 246HIS A 329ALA A 184PHE A 241 | ZN A 501 ( 2.5A) ZN A 501 ( 2.3A)TLA A 502 (-4.0A)NoneNone | 1.40A | 3r2jC-4mrqA:undetectable | 3r2jC-4mrqA:20.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3SG9_B_KANB305_1 (APH(2'')-ID) |
4it1 | PUTATIVE GLUCARATEDEHYDRATASE (Pseudomonasfluorescens) | 4 / 8 | ASN A 269HIS A 349ASP A 347GLU A 202 | MG A 501 (-2.5A)TLA A 502 (-4.7A)NoneNone | 1.10A | 3sg9B-4it1A:undetectable | 3sg9B-4it1A:20.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3SUD_D_SUED1201_1 (NS3 PROTEASE, NS4APROTEIN) |
4it1 | PUTATIVE GLUCARATEDEHYDRATASE (Pseudomonasfluorescens) | 5 / 12 | GLY A 195ASP A 221GLY A 23ALA A 98SER A 101 | None MG A 501 (-2.6A)NoneTLA A 502 ( 4.8A)None | 0.89A | 3sudD-4it1A:undetectable | 3sudD-4it1A:19.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3T3Q_C_9PLC501_1 (CYTOCHROME P450 2A6) |
2jfw | GLUTAMATE RACEMASE (Enterococcusfaecium) | 5 / 10 | VAL A 99ASN A 78ALA A 80THR A 58ILE A 13 | NoneTLA A1272 (-4.3A)NoneNoneNone | 1.37A | 3t3qC-2jfwA:undetectable | 3t3qC-2jfwA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3T7S_C_SAMC300_0 (PUTATIVEMETHYLTRANSFERASE) |
2cve | HYPOTHETICAL PROTEINTTHA1053 (Thermusthermophilus) | 5 / 12 | GLY A 103GLY A 100GLN A 16ALA A 107TYR A 108 | NoneTLA A 192 (-3.5A)NoneNoneNone | 1.39A | 3t7sC-2cveA:undetectable | 3t7sC-2cveA:19.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3U5J_A_08HA1_1 (BROMODOMAIN-CONTAINING PROTEIN 4) |
5uib | OXIDOREDUCTASEPROTEIN (Agrobacteriumtumefaciens) | 4 / 7 | PRO A 242LEU A 179ASN A 126ILE A 291 | NoneTLA A 402 (-4.0A)NAD A 401 (-3.0A)NAD A 401 ( 4.7A) | 0.98A | 3u5jA-5uibA:undetectable | 3u5jA-5uibA:13.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3U5K_D_08JD4_1 (BROMODOMAIN-CONTAINING PROTEIN 4) |
5uib | OXIDOREDUCTASEPROTEIN (Agrobacteriumtumefaciens) | 4 / 8 | PRO A 242LEU A 179ASN A 126ILE A 291 | NoneTLA A 402 (-4.0A)NAD A 401 (-3.0A)NAD A 401 ( 4.7A) | 0.82A | 3u5kD-5uibA:undetectable | 3u5kD-5uibA:13.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UA1_A_08YA600_1 (CYTOCHROME P450 3A4) |
3mwe | ATP-CITRATE SYNTHASE (Homosapiens) | 5 / 12 | ARG A 378ILE A 414PHE A 354ALA A 284ALA A 345 | NoneNoneNoneNoneTLA A 427 (-3.6A) | 1.36A | 3ua1A-3mweA:undetectable | 3ua1A-3mweA:21.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UBO_B_ADNB353_2 (ADENOSINE KINASE) |
5u9p | GLUCONATE5-DEHYDROGENASE (Burkholderiacenocepacia) | 4 / 5 | SER A 148ILE A 24TYR A 161GLY A 192 | TLA A 302 (-2.9A)NAP A 301 (-3.9A)TLA A 302 ( 4.0A)None | 0.90A | 3uboB-5u9pA:5.7 | 3uboB-5u9pA:23.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UF8_A_FK5A114_1 (UBIQUITIN-LIKEPROTEIN SMT3,PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 6 / 10 | PHE A 166ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.6A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 1.13A | 3uf8A-5xb0A:16.8 | 3uf8A-5xb0A:31.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UF8_A_FK5A114_1 (UBIQUITIN-LIKEPROTEIN SMT3,PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 8 / 10 | TYR A 147ASP A 158VAL A 171ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 0.71A | 3uf8A-5xb0A:16.8 | 3uf8A-5xb0A:31.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UQA_A_FK5A114_1 (UBIQUITIN-LIKEPROTEIN SMT3,PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 6 / 10 | PHE A 166ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.6A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 1.14A | 3uqaA-5xb0A:16.7 | 3uqaA-5xb0A:32.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UQA_A_FK5A114_1 (UBIQUITIN-LIKEPROTEIN SMT3,PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 8 / 10 | TYR A 147ASP A 158VAL A 171ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 0.73A | 3uqaA-5xb0A:16.7 | 3uqaA-5xb0A:32.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UQB_A_FK5A114_1 (UBIQUITIN-LIKEPROTEIN SMT3,PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 6 / 8 | TYR A 147VAL A 171ILE A 172TRP A 175TYR A 198PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNone | 0.40A | 3uqbA-5xb0A:16.8 | 3uqbA-5xb0A:31.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UQB_A_FK5A114_1 (UBIQUITIN-LIKEPROTEIN SMT3,PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 6 / 8 | TYR A 147VAL A 171ILE A 172TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 0.53A | 3uqbA-5xb0A:16.8 | 3uqbA-5xb0A:31.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3VAW_A_FK5A114_1 (UBIQUITIN-LIKEPROTEINSMT3,PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 6 / 11 | PHE A 166ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.6A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 1.16A | 3vawA-5xb0A:15.7 | 3vawA-5xb0A:32.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3VAW_A_FK5A114_1 (UBIQUITIN-LIKEPROTEINSMT3,PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 8 / 11 | TYR A 147ASP A 158VAL A 171ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 0.74A | 3vawA-5xb0A:15.7 | 3vawA-5xb0A:32.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3VYW_A_SAMA501_1 (MNMC2) |
5mux | 2-METHYLCITRATEDEHYDRATASE (Bacillussubtilis) | 4 / 6 | HIS A 144ASP A 334ASP A 95GLU A 282 | NoneNoneNoneTLA A 501 (-3.4A) | 1.30A | 3vywA-5muxA:undetectable | 3vywA-5muxA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4AQL_A_TXCA1452_1 (GUANINE DEAMINASE) |
2cve | HYPOTHETICAL PROTEINTTHA1053 (Thermusthermophilus) | 5 / 12 | LEU A 104LEU A 99PHE A 20GLU A 65HIS A 47 | TLA A 192 (-4.5A)TLA A 192 (-4.3A)NoneTLA A 192 (-3.1A)None | 0.94A | 4aqlA-2cveA:undetectable | 4aqlA-2cveA:18.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4BUP_B_SAMB500_1 (HISTONE-LYSINEN-METHYLTRANSFERASESUV420H1) |
3os7 | GALACTOSEMUTAROTASE-LIKEPROTEIN (Clostridiumacetobutylicum) | 3 / 3 | HIS A 108GLU A 100ASN A 216 | TLA A 401 (-3.9A)NoneNone | 1.04A | 4bupB-3os7A:undetectable | 4bupB-3os7A:21.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4BUP_B_SAMB500_1 (HISTONE-LYSINEN-METHYLTRANSFERASESUV420H1) |
4it1 | PUTATIVE GLUCARATEDEHYDRATASE (Pseudomonasfluorescens) | 3 / 3 | HIS A 320GLU A 246ASN A 223 | None MG A 501 (-2.8A)TLA A 502 (-3.7A) | 0.89A | 4bupB-4it1A:undetectable | 4bupB-4it1A:21.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
2c1l | RESTRICTIONENDONUCLEASE (Bacillusfirmus) | 3 / 3 | ASN A 46LEU A 40PHE A 44 | NoneNoneTLA A1363 (-4.1A) | 0.64A | 4dajB-2c1lA:undetectable | 4dajB-2c1lA:21.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DRH_A_RAPA201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 8 / 12 | TYR A 147ASP A 158PHE A 166ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 ( 4.6A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 1.12A | 4drhA-5xb0A:16.1 | 4drhA-5xb0A:30.87 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DRH_A_RAPA201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 8 / 12 | TYR A 147ASP A 158VAL A 171ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 0.75A | 4drhA-5xb0A:16.1 | 4drhA-5xb0A:30.87 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DRH_D_RAPD201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 7 / 12 | ASP A 158PHE A 166ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 (-3.7A)TLA A 301 ( 4.6A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 1.16A | 4drhD-5xb0A:16.0 | 4drhD-5xb0A:30.87 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DRH_D_RAPD201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 8 / 12 | TYR A 147ASP A 158VAL A 171ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 0.74A | 4drhD-5xb0A:16.0 | 4drhD-5xb0A:30.87 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DRI_A_RAPA201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 8 / 11 | TYR A 147ASP A 158PHE A 166ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 ( 4.6A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 1.04A | 4driA-5xb0A:16.6 | 4driA-5xb0A:30.87 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DRI_A_RAPA201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 8 / 11 | TYR A 147ASP A 158VAL A 171ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 0.66A | 4driA-5xb0A:16.6 | 4driA-5xb0A:30.87 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DRJ_A_RAPA201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 8 / 11 | TYR A 147ASP A 158PHE A 166ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 ( 4.6A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 1.05A | 4drjA-5xb0A:16.5 | 4drjA-5xb0A:31.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DRJ_A_RAPA201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 8 / 11 | TYR A 147ASP A 158VAL A 171ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 0.67A | 4drjA-5xb0A:16.5 | 4drjA-5xb0A:31.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DZ2_A_FK5A200_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 6 / 11 | PHE A 166ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.6A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 1.12A | 4dz2A-5xb0A:16.64dz2B-5xb0A:16.6 | 4dz2A-5xb0A:37.504dz2B-5xb0A:37.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DZ2_A_FK5A200_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 8 / 11 | TYR A 147ASP A 158VAL A 171ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 0.70A | 4dz2A-5xb0A:16.64dz2B-5xb0A:16.6 | 4dz2A-5xb0A:37.504dz2B-5xb0A:37.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DZ2_B_FK5B200_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 6 / 11 | PHE A 166ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.6A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 1.12A | 4dz2A-5xb0A:16.64dz2B-5xb0A:16.6 | 4dz2A-5xb0A:37.504dz2B-5xb0A:37.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DZ2_B_FK5B200_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 8 / 11 | TYR A 147ASP A 158VAL A 171ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 0.67A | 4dz2A-5xb0A:16.64dz2B-5xb0A:16.6 | 4dz2A-5xb0A:37.504dz2B-5xb0A:37.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DZ3_A_FK5A201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 7 / 10 | PHE A 166VAL A 171ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.6A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 1.06A | 4dz3A-5xb0A:16.6 | 4dz3A-5xb0A:37.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DZ3_A_FK5A201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 8 / 10 | TYR A 147ASP A 158VAL A 171ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 0.70A | 4dz3A-5xb0A:16.6 | 4dz3A-5xb0A:37.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DZ3_B_FK5B201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 7 / 10 | PHE A 166VAL A 171ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.6A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 1.07A | 4dz3B-5xb0A:16.6 | 4dz3B-5xb0A:37.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DZ3_B_FK5B201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 8 / 10 | TYR A 147ASP A 158VAL A 171ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 0.72A | 4dz3B-5xb0A:16.6 | 4dz3B-5xb0A:37.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) |
2pyx | TRYPTOPHANHALOGENASE (Shewanellafrigidimarina) | 5 / 12 | ILE A 347ALA A 348ALA A 17GLY A 15THR A 21 | NoneNoneTLA A 527 (-3.3A)TLA A 527 (-3.2A)None | 1.08A | 4enhA-2pyxA:undetectable | 4enhA-2pyxA:22.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4EY6_A_GNTA604_1 (ACETYLCHOLINESTERASE) |
1zl0 | HYPOTHETICAL PROTEINPA5198 (Pseudomonasaeruginosa) | 5 / 12 | GLY A 87GLY A 88SER A 25SER A 115HIS A 285 | EDO A1407 (-3.5A)EDO A1408 ( 3.4A)NoneTLA A1401 ( 2.0A)EDO A1407 ( 3.9A) | 0.92A | 4ey6A-1zl0A:3.5 | 4ey6A-1zl0A:23.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FFW_B_715B801_1 (DIPEPTIDYL PEPTIDASE4) |
3ekg | MANDELATERACEMASE/MUCONATELACTONIZING ENZYME (Azotobactervinelandii) | 5 / 12 | GLU A 340GLY A 164PHE A 175SER A 326VAL A 330 | TLA A 501 (-2.8A)NoneNoneNoneNone | 1.37A | 4ffwB-3ekgA:undetectable | 4ffwB-3ekgA:19.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4HTF_A_ACTA303_0 (S-ADENOSYLMETHIONINE-DEPENDENTMETHYLTRANSFERASE) |
5mux | 2-METHYLCITRATEDEHYDRATASE (Bacillussubtilis) | 3 / 3 | TYR A 203HIS A 163ARG A 204 | NoneTLA A 501 (-3.9A)TLA A 501 (-3.9A) | 1.01A | 4htfA-5muxA:undetectable | 4htfA-5muxA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4IIZ_A_LURA201_1 (TRANSTHYRETIN) |
3i5b | WSPR RESPONSEREGULATOR (Pseudomonasaeruginosa) | 3 / 3 | LYS A 327LEU A 323ALA A 326 | TLA A 2 (-2.8A)NoneNone | 0.81A | 4iizA-3i5bA:undetectable | 4iizA-3i5bA:22.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4IKI_A_IMNA201_1 (TRANSTHYRETIN) |
3i5b | WSPR RESPONSEREGULATOR (Pseudomonasaeruginosa) | 3 / 3 | LYS A 327LEU A 323ALA A 326 | TLA A 2 (-2.8A)NoneNone | 0.70A | 4ikiA-3i5bA:undetectable | 4ikiA-3i5bA:22.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4KN2_A_LYAA304_1 (FOLATE RECEPTOR BETA) |
3d46 | PUTATIVE GALACTONATEDEHYDRATASE (Salmonellaenterica) | 5 / 12 | THR A 173SER A 58ARG A 59HIS A 33GLY A 26 | TLA A 502 (-3.6A)NoneTLA A 502 (-2.6A)TLA A 502 (-3.8A)None | 1.41A | 4kn2A-3d46A:undetectable | 4kn2A-3d46A:17.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4KN2_C_LYAC304_1 (FOLATE RECEPTOR BETA) |
3d46 | PUTATIVE GALACTONATEDEHYDRATASE (Salmonellaenterica) | 5 / 12 | THR A 173SER A 58ARG A 59HIS A 33GLY A 26 | TLA A 502 (-3.6A)NoneTLA A 502 (-2.6A)TLA A 502 (-3.8A)None | 1.41A | 4kn2C-3d46A:undetectable | 4kn2C-3d46A:17.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4KRH_B_SAMB900_0 (PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE2) |
3dme | CONSERVED EXPORTEDPROTEIN (Bordetellapertussis) | 5 / 12 | TYR A 57LEU A 62SER A 61ALA A 330ARG A 316 | NoneNoneNoneNoneTLA A 999 ( 4.0A) | 1.16A | 4krhB-3dmeA:3.3 | 4krhB-3dmeA:22.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4KRH_B_SAMB900_0 (PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE2) |
3dme | CONSERVED EXPORTEDPROTEIN (Bordetellapertussis) | 5 / 12 | TYR A 57LEU A 62SER A 61ARG A 316ILE A 359 | NoneNoneNoneTLA A 999 ( 4.0A)None | 1.15A | 4krhB-3dmeA:3.3 | 4krhB-3dmeA:22.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4KUO_A_RBFA500_1 (BLUE-LIGHTPHOTORECEPTOR) |
5ygu | DIAMINOPIMELATEEPIMERASE (Escherichiacoli) | 5 / 12 | VAL A 206ASN A 11GLN A 72LEU A 247ASN A 157 | NoneIOD A 308 (-4.5A)TLA A 301 (-3.2A)NoneTLA A 301 (-3.4A) | 1.37A | 4kuoA-5yguA:undetectable | 4kuoA-5yguA:20.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4LAX_A_FK5A301_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 8 / 10 | TYR A 147ASP A 158VAL A 171ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 0.68A | 4laxA-5xb0A:16.5 | 4laxA-5xb0A:28.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4LAX_A_FK5A301_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 7 / 10 | TYR A 147PHE A 166ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 ( 4.6A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 1.02A | 4laxA-5xb0A:16.5 | 4laxA-5xb0A:28.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4MWV_A_BCZA513_1 (NEURAMINIDASE) |
5o9h | C5A ANAPHYLATOXINCHEMOTACTIC RECEPTOR1 (Homosapiens) | 3 / 3 | ARG A 148GLU A 326ARG A 134 | TLA A 402 (-3.2A)TLA A 402 (-3.6A)None | 0.66A | 4mwvA-5o9hA:undetectable | 4mwvA-5o9hA:undetectable | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NNR_A_FK5A201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP2) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 6 / 12 | PHE A 166ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.6A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 1.11A | 4nnrA-5xb0A:12.14nnrB-5xb0A:12.4 | 4nnrA-5xb0A:34.234nnrB-5xb0A:34.23 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NNR_A_FK5A201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP2) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 8 / 12 | TYR A 147ASP A 158VAL A 171ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 0.69A | 4nnrA-5xb0A:12.14nnrB-5xb0A:12.4 | 4nnrA-5xb0A:34.234nnrB-5xb0A:34.23 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NNR_B_FK5B201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP2) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 6 / 10 | PHE A 166ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.6A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 1.13A | 4nnrB-5xb0A:12.4 | 4nnrB-5xb0A:34.23 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NNR_B_FK5B201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP2) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 8 / 10 | TYR A 147ASP A 158VAL A 171ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 0.75A | 4nnrB-5xb0A:12.4 | 4nnrB-5xb0A:34.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4OBW_A_SAMA602_0 (2-METHOXY-6-POLYPRENYL-1,4-BENZOQUINOLMETHYLASE,MITOCHONDRIAL) |
5u9p | GLUCONATE5-DEHYDROGENASE (Burkholderiacenocepacia) | 5 / 12 | TYR A 161GLY A 98ILE A 24GLY A 23ASN A 199 | TLA A 302 ( 4.0A)NAP A 301 (-3.8A)NAP A 301 (-3.9A)NAP A 301 (-3.5A)TLA A 302 ( 3.0A) | 1.17A | 4obwA-5u9pA:7.2 | 4obwA-5u9pA:21.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4OBW_D_SAMD601_0 (2-METHOXY-6-POLYPRENYL-1,4-BENZOQUINOLMETHYLASE,MITOCHONDRIAL) |
5u9p | GLUCONATE5-DEHYDROGENASE (Burkholderiacenocepacia) | 5 / 12 | TYR A 161GLY A 98ILE A 24GLY A 23ASN A 199 | TLA A 302 ( 4.0A)NAP A 301 (-3.8A)NAP A 301 (-3.9A)NAP A 301 (-3.5A)TLA A 302 ( 3.0A) | 1.15A | 4obwD-5u9pA:6.4 | 4obwD-5u9pA:21.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ODO_A_FK5A205_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASESLYD) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 5 / 10 | TYR A 147ASP A 158ILE A 172TYR A 198PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)NoneNone | 0.70A | 4odoA-5xb0A:9.7 | 4odoA-5xb0A:22.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ODO_B_FK5B203_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASESLYD) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 5 / 10 | TYR A 147ASP A 158ILE A 172TYR A 198PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)NoneNone | 0.66A | 4odoB-5xb0A:9.4 | 4odoB-5xb0A:22.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ODO_C_FK5C204_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASESLYD) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 5 / 10 | TYR A 147ASP A 158ILE A 172TYR A 198PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)NoneNone | 0.70A | 4odoC-5xb0A:9.3 | 4odoC-5xb0A:22.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ODR_B_FK5B201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASESLYD,PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1A CHIMERA) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 5 / 11 | TYR A 147ASP A 158ILE A 172TYR A 198PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)NoneNone | 0.67A | 4odrA-5xb0A:10.94odrB-5xb0A:11.0 | 4odrA-5xb0A:22.734odrB-5xb0A:22.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4OLT_A_GCSA303_1 (CHITOSANASE) |
5n6c | D-3-PHOSPHOGLYCERATEDEHYDROGENASE (Homosapiens) | 4 / 6 | ASP A 81ARG A 236GLY A 238HIS A 283 | NoneTLA A 401 ( 2.7A)NoneTLA A 401 ( 3.8A) | 0.98A | 4oltA-5n6cA:undetectable | 4oltA-5n6cA:18.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4OLT_B_GCSB303_1 (CHITOSANASE) |
5n6c | D-3-PHOSPHOGLYCERATEDEHYDROGENASE (Homosapiens) | 4 / 6 | ASP A 81ARG A 236GLY A 238HIS A 283 | NoneTLA A 401 ( 2.7A)NoneTLA A 401 ( 3.8A) | 1.00A | 4oltB-5n6cA:undetectable | 4oltB-5n6cA:18.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4QA0_A_SHHA404_1 (HISTONE DEACETYLASE8) |
4mrq | PHOSPHOMANNOMUTASE/PHOSPHOGLUCOMUTASE (Pseudomonasaeruginosa) | 5 / 12 | TYR A 259HIS A 329GLY A 328ASP A 244GLY A 245 | PEG A 504 ( 4.2A)TLA A 502 (-4.0A)None ZN A 501 ( 2.5A)None | 1.29A | 4qa0A-4mrqA:undetectable | 4qa0A-4mrqA:20.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4QA2_A_SHHA404_1 (HISTONE DEACETYLASE8) |
4mrq | PHOSPHOMANNOMUTASE/PHOSPHOGLUCOMUTASE (Pseudomonasaeruginosa) | 5 / 12 | TYR A 259HIS A 329GLY A 328ASP A 244GLY A 245 | PEG A 504 ( 4.2A)TLA A 502 (-4.0A)None ZN A 501 ( 2.5A)None | 1.23A | 4qa2A-4mrqA:undetectable | 4qa2A-4mrqA:20.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4QA2_B_SHHB404_1 (HISTONE DEACETYLASE8) |
4mrq | PHOSPHOMANNOMUTASE/PHOSPHOGLUCOMUTASE (Pseudomonasaeruginosa) | 5 / 12 | TYR A 259HIS A 329GLY A 328ASP A 244GLY A 245 | PEG A 504 ( 4.2A)TLA A 502 (-4.0A)None ZN A 501 ( 2.5A)None | 1.18A | 4qa2B-4mrqA:undetectable | 4qa2B-4mrqA:20.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4QKN_A_JMSA602_1 (ALPHA-KETOGLUTARATE-DEPENDENTDIOXYGENASE FTO) |
1vpd | TARTRONATESEMIALDEHYDEREDUCTASE (Salmonellaenterica) | 4 / 8 | LEU A 217THR A 215VAL A 179HIS A 279 | NoneNoneTLA A 501 ( 4.7A)TLA A 501 (-4.8A) | 0.88A | 4qknA-1vpdA:0.0 | 4qknA-1vpdA:20.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4QT2_A_RAPA202_1 (FK506-BINDINGPROTEIN (FKBP)-TYPEPEPTIDYL-PROPYLISOMERASE) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 7 / 10 | ASP A 158PHE A 166ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 (-3.7A)TLA A 301 ( 4.6A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 1.14A | 4qt2A-5xb0A:16.3 | 4qt2A-5xb0A:33.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4QT2_A_RAPA202_1 (FK506-BINDINGPROTEIN (FKBP)-TYPEPEPTIDYL-PROPYLISOMERASE) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 8 / 10 | TYR A 147ASP A 158VAL A 171ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 0.72A | 4qt2A-5xb0A:16.3 | 4qt2A-5xb0A:33.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4QT3_A_RAPA202_1 (FK506-BINDINGPROTEIN (FKBP)-TYPEPEPTIDYL-PROPYLISOMERASE) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 8 / 10 | TYR A 147ASP A 158PHE A 166ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 ( 4.6A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 1.06A | 4qt3A-5xb0A:15.6 | 4qt3A-5xb0A:33.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4QT3_A_RAPA202_1 (FK506-BINDINGPROTEIN (FKBP)-TYPEPEPTIDYL-PROPYLISOMERASE) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 8 / 10 | TYR A 147ASP A 158VAL A 171ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 0.68A | 4qt3A-5xb0A:15.6 | 4qt3A-5xb0A:33.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4QVN_K_BO2K301_1 (PROTEASOME SUBUNITBETA TYPE-5PROTEASOME SUBUNITBETA TYPE-6) |
1fs5 | GLUCOSAMINE-6-PHOSPHATE DEAMINASE (Escherichiacoli) | 5 / 9 | THR A 44ALA A 169VAL A 203GLY A 137ASP A 141 | TLA A1268 (-3.5A)NoneNoneNoneNone | 1.03A | 4qvnK-1fs5A:undetectable4qvnL-1fs5A:undetectable | 4qvnK-1fs5A:20.864qvnL-1fs5A:22.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4QVN_Y_BO2Y301_1 (PROTEASOME SUBUNITBETA TYPE-5PROTEASOME SUBUNITBETA TYPE-6) |
1fs5 | GLUCOSAMINE-6-PHOSPHATE DEAMINASE (Escherichiacoli) | 5 / 9 | THR A 44ALA A 169VAL A 203GLY A 137ASP A 141 | TLA A1268 (-3.5A)NoneNoneNoneNone | 1.03A | 4qvnY-1fs5A:undetectable4qvnZ-1fs5A:undetectable | 4qvnY-1fs5A:20.864qvnZ-1fs5A:22.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4R7L_A_SHHA709_1 (LEUKOTRIENE A-4HYDROLASE) |
5uib | OXIDOREDUCTASEPROTEIN (Agrobacteriumtumefaciens) | 5 / 12 | GLN A 97ALA A 74GLU A 125HIS A 182PHE A 16 | NAD A 401 (-3.2A)NoneNoneTLA A 402 ( 3.9A)NAD A 401 (-3.3A) | 1.26A | 4r7lA-5uibA:undetectable | 4r7lA-5uibA:19.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4V1F_A_BQ1A1087_0 (F0F1 ATP SYNTHASESUBUNIT C) |
3zm8 | GH26ENDO-BETA-1,4-MANNANASE (Podosporaanserina) | 3 / 3 | GLU A 300ALA A 301PHE A 306 | TLA A1452 (-2.8A)NoneNone | 0.53A | 4v1fA-3zm8A:undetectable | 4v1fA-3zm8A:13.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4V1F_C_BQ1C1087_0 (F0F1 ATP SYNTHASESUBUNIT C) |
3zm8 | GH26ENDO-BETA-1,4-MANNANASE (Podosporaanserina) | 3 / 3 | GLU A 300ALA A 301PHE A 306 | TLA A1452 (-2.8A)NoneNone | 0.52A | 4v1fC-3zm8A:undetectable | 4v1fC-3zm8A:13.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YMG_B_SAMB1001_1 (PUTATIVESAM-DEPENDENTO-METHYLTRANFERASE) |
3d46 | PUTATIVE GALACTONATEDEHYDRATASE (Salmonellaenterica) | 3 / 3 | SER A 50GLU A 253GLU A 349 | NoneNoneTLA A 502 (-2.8A) | 0.68A | 4ymgB-3d46A:undetectable | 4ymgB-3d46A:20.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5AYA_A_X8ZA307_1 (METALLO-BETA-LACTAMASE) |
5aho | 5' EXONUCLEASEAPOLLO (Homosapiens) | 5 / 11 | HIS A 31HIS A 33ASP A 35HIS A 36HIS A 99 | ZN A1321 (-3.3A) ZN A1321 ( 3.2A)TLA A1319 ( 2.7A) ZN A1320 ( 3.4A) ZN A1321 ( 3.4A) | 0.33A | 5ayaA-5ahoA:7.9 | 5ayaA-5ahoA:20.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5B8I_C_FK5C201_3 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 8 / 12 | TYR A 147ASP A 158VAL A 171ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 0.68A | 5b8iC-5xb0A:15.2 | 5b8iC-5xb0A:31.76 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5B8I_C_FK5C201_3 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 7 / 12 | TYR A 147PHE A 166ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 ( 4.6A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 1.07A | 5b8iC-5xb0A:15.2 | 5b8iC-5xb0A:31.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5BYJ_A_OQRA302_0 (SULFOTRANSFERASE) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 5 / 12 | PHE A 215ILE A 192VAL A 171GLY A 199THR A 176 | NoneNoneTLA A 301 (-3.4A)NoneNone | 1.07A | 5byjA-5xb0A:undetectable | 5byjA-5xb0A:19.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5D4U_A_SAMA301_0 (UNCHARACTERIZEDPROTEIN MJ0489) |
3d46 | PUTATIVE GALACTONATEDEHYDRATASE (Salmonellaenterica) | 5 / 12 | GLY A 174LEU A 179ILE A 41HIS A 39THR A 173 | NoneNoneNoneNoneTLA A 502 (-3.6A) | 1.03A | 5d4uA-3d46A:undetectable | 5d4uA-3d46A:21.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5D4U_A_SAMA301_0 (UNCHARACTERIZEDPROTEIN MJ0489) |
3ekg | MANDELATERACEMASE/MUCONATELACTONIZING ENZYME (Azotobactervinelandii) | 5 / 12 | GLY A 164LEU A 169ILE A 32HIS A 30THR A 163 | NoneNoneNoneNoneTLA A 501 ( 3.8A) | 1.07A | 5d4uA-3ekgA:undetectable | 5d4uA-3ekgA:19.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5D4U_B_SAMB301_0 (UNCHARACTERIZEDPROTEIN MJ0489) |
3d46 | PUTATIVE GALACTONATEDEHYDRATASE (Salmonellaenterica) | 5 / 12 | GLY A 174LEU A 179ILE A 41HIS A 39THR A 173 | NoneNoneNoneNoneTLA A 502 (-3.6A) | 1.02A | 5d4uB-3d46A:undetectable | 5d4uB-3d46A:21.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5D4U_B_SAMB301_0 (UNCHARACTERIZEDPROTEIN MJ0489) |
3ekg | MANDELATERACEMASE/MUCONATELACTONIZING ENZYME (Azotobactervinelandii) | 5 / 12 | GLY A 164LEU A 169ILE A 32HIS A 30THR A 163 | NoneNoneNoneNoneTLA A 501 ( 3.8A) | 1.06A | 5d4uB-3ekgA:undetectable | 5d4uB-3ekgA:19.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5D4U_C_SAMC301_0 (UNCHARACTERIZEDPROTEIN MJ0489) |
3d46 | PUTATIVE GALACTONATEDEHYDRATASE (Salmonellaenterica) | 5 / 12 | GLY A 174LEU A 179ILE A 41HIS A 39THR A 173 | NoneNoneNoneNoneTLA A 502 (-3.6A) | 1.03A | 5d4uC-3d46A:undetectable | 5d4uC-3d46A:21.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5D75_A_FK5A301_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP3) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 8 / 11 | TYR A 147ASP A 158VAL A 171ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 0.59A | 5d75A-5xb0A:15.5 | 5d75A-5xb0A:31.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5DV4_A_NMYA601_1 (CCR4-NOTTRANSCRIPTIONCOMPLEX SUBUNIT6-LIKE) |
5aho | 5' EXONUCLEASEAPOLLO (Homosapiens) | 5 / 12 | ASN A 148HIS A 276ASP A 120ILE A 297HIS A 36 | NoneTLA A1319 ( 3.9A) ZN A1320 (-2.5A)None ZN A1320 ( 3.4A) | 1.31A | 5dv4A-5ahoA:undetectable | 5dv4A-5ahoA:22.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5DZK_O_BEZO801_0 (ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 2BEZ-LEU-LEU) |
4it1 | PUTATIVE GLUCARATEDEHYDRATASE (Pseudomonasfluorescens) | 4 / 6 | SER A 101HIS A 102PRO A 99LEU A 97 | NoneNoneTLA A 502 (-4.3A)None | 1.22A | 5dzka-4it1A:2.05dzko-4it1A:undetectable | 5dzka-4it1A:21.165dzko-4it1A:4.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5DZK_T_BEZT801_0 (ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 2BEZ-LEU-LEU) |
3hzn | OXYGEN-INSENSITIVENAD(P)HNITROREDUCTASE (Salmonellaenterica) | 4 / 5 | SER A 79ALA A 78HIS A 80LEU A 159 | NoneNoneTLA A 218 (-4.0A)None | 1.38A | 5dzkf-3hznA:undetectable5dzkt-3hznA:undetectable | 5dzkf-3hznA:22.185dzkt-3hznA:1.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5E4D_A_BEZA201_0 (HYDROXYNITRILE LYASE) |
5uib | OXIDOREDUCTASEPROTEIN (Agrobacteriumtumefaciens) | 5 / 9 | VAL A 230VAL A 228ILE A 186PHE A 127LEU A 179 | NoneNoneNoneNoneTLA A 402 (-4.0A) | 1.46A | 5e4dA-5uibA:undetectable | 5e4dA-5uibA:19.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5GPG_A_RAPA301_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP3) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 8 / 11 | TYR A 147ASP A 158VAL A 171ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 0.64A | 5gpgA-5xb0A:15.9 | 5gpgA-5xb0A:31.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5GWX_A_SAMA301_1 (GLYCINE SARCOSINEN-METHYLTRANSFERASE) |
4it1 | PUTATIVE GLUCARATEDEHYDRATASE (Pseudomonasfluorescens) | 3 / 3 | ARG A 404ASN A 322ASP A 221 | TLA A 502 (-2.9A)TLA A 502 ( 4.8A) MG A 501 (-2.6A) | 0.74A | 5gwxA-4it1A:undetectable | 5gwxA-4it1A:20.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HES_A_032A401_2 (MITOGEN-ACTIVATEDPROTEIN KINASEKINASE KINASE MLT) |
5uib | OXIDOREDUCTASEPROTEIN (Agrobacteriumtumefaciens) | 4 / 6 | PHE A 323SER A 231VAL A 230ASP A 178 | NoneNoneNoneTLA A 402 (-3.4A) | 1.27A | 5hesA-5uibA:undetectable | 5hesA-5uibA:20.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HKG_A_RAPA201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1B) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 7 / 12 | TYR A 147ASP A 158PHE A 166ILE A 172TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 ( 4.6A)TLA A 301 (-3.4A)NoneNoneNone | 1.12A | 5hkgA-5xb0A:15.0 | 5hkgA-5xb0A:29.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HKG_A_RAPA201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1B) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 7 / 12 | TYR A 147ASP A 158VAL A 171ILE A 172TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 0.70A | 5hkgA-5xb0A:15.0 | 5hkgA-5xb0A:29.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HUA_A_FK5A201_1 (FK506-BINDINGPROTEIN 1) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 5 / 11 | PHE A 166ILE A 172TRP A 175TYR A 198PHE A 215 | TLA A 301 ( 4.6A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNone | 1.13A | 5huaA-5xb0A:17.5 | 5huaA-5xb0A:30.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HUA_A_FK5A201_1 (FK506-BINDINGPROTEIN 1) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 7 / 11 | TYR A 147ASP A 158VAL A 171ILE A 172TRP A 175TYR A 198PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNone | 0.61A | 5huaA-5xb0A:17.5 | 5huaA-5xb0A:30.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HW8_A_FK5A201_1 (FK506-BINDINGPROTEIN 1) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 7 / 11 | TYR A 147ASP A 158VAL A 171ILE A 172TRP A 175TYR A 198ILE A 207 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNone | 0.65A | 5hw8A-5xb0A:15.15hw8D-5xb0A:15.2 | 5hw8A-5xb0A:27.945hw8D-5xb0A:27.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HW8_B_FK5B201_1 (FK506-BINDINGPROTEIN 1) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 5 / 11 | PHE A 166TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.6A)TLA A 301 (-3.4A)NoneNoneNone | 1.14A | 5hw8B-5xb0A:15.1 | 5hw8B-5xb0A:27.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HW8_B_FK5B201_1 (FK506-BINDINGPROTEIN 1) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 7 / 11 | TYR A 147ASP A 158VAL A 171TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 0.63A | 5hw8B-5xb0A:15.1 | 5hw8B-5xb0A:27.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HW8_B_FK5B201_1 (FK506-BINDINGPROTEIN 1) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 5 / 11 | TYR A 147VAL A 171TRP A 175ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNone | 1.22A | 5hw8B-5xb0A:15.1 | 5hw8B-5xb0A:27.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HW8_C_FK5C201_1 (FK506-BINDINGPROTEIN 1) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 8 / 10 | TYR A 147ASP A 158VAL A 171ILE A 172TRP A 175TYR A 198LEU A 213PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 0.53A | 5hw8C-5xb0A:15.25hw8H-5xb0A:12.8 | 5hw8C-5xb0A:27.945hw8H-5xb0A:27.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HW8_D_FK5D201_1 (FK506-BINDINGPROTEIN 1) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 6 / 11 | PHE A 166ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.6A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 1.07A | 5hw8D-5xb0A:15.2 | 5hw8D-5xb0A:27.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HW8_D_FK5D201_1 (FK506-BINDINGPROTEIN 1) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 8 / 11 | TYR A 147ASP A 158VAL A 171ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 0.67A | 5hw8D-5xb0A:15.2 | 5hw8D-5xb0A:27.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HW8_E_FK5E201_1 (FK506-BINDINGPROTEIN 1) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 5 / 11 | PHE A 166ILE A 172TRP A 175TYR A 198PHE A 215 | TLA A 301 ( 4.6A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNone | 1.13A | 5hw8E-5xb0A:15.1 | 5hw8E-5xb0A:27.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HW8_E_FK5E201_1 (FK506-BINDINGPROTEIN 1) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 7 / 11 | TYR A 147ASP A 158VAL A 171ILE A 172TRP A 175TYR A 198PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNone | 0.73A | 5hw8E-5xb0A:15.1 | 5hw8E-5xb0A:27.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HW8_F_FK5F201_1 (FK506-BINDINGPROTEIN 1) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 7 / 12 | TYR A 147ASP A 158VAL A 171ILE A 172TRP A 175TYR A 198PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNone | 0.76A | 5hw8B-5xb0A:15.15hw8F-5xb0A:12.25hw8G-5xb0A:15.2 | 5hw8B-5xb0A:27.945hw8F-5xb0A:27.945hw8G-5xb0A:27.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HW8_F_FK5F201_1 (FK506-BINDINGPROTEIN 1) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 6 / 12 | TYR A 147PHE A 166ILE A 172TRP A 175TYR A 198PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 ( 4.6A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNone | 1.03A | 5hw8B-5xb0A:15.15hw8F-5xb0A:12.25hw8G-5xb0A:15.2 | 5hw8B-5xb0A:27.945hw8F-5xb0A:27.945hw8G-5xb0A:27.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HW8_G_FK5G201_2 (FK506-BINDINGPROTEIN 1) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 6 / 11 | PHE A 166ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.6A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 1.06A | 5hw8G-5xb0A:15.2 | 5hw8G-5xb0A:27.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HW8_G_FK5G201_2 (FK506-BINDINGPROTEIN 1) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 8 / 11 | TYR A 147ASP A 158VAL A 171ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 0.68A | 5hw8G-5xb0A:15.2 | 5hw8G-5xb0A:27.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HW8_H_FK5H201_1 (FK506-BINDINGPROTEIN 1) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 6 / 8 | TYR A 147ASP A 158VAL A 171ILE A 172TRP A 175PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)None | 0.78A | 5hw8H-5xb0A:12.8 | 5hw8H-5xb0A:27.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HWC_A_FK5A201_1 (FK506-BINDINGPROTEIN 1A) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 8 / 11 | TYR A 147ASP A 158VAL A 171ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 0.68A | 5hwcA-5xb0A:16.1 | 5hwcA-5xb0A:31.03 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HWC_A_FK5A201_1 (FK506-BINDINGPROTEIN 1A) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 7 / 11 | TYR A 147PHE A 166ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 ( 4.6A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 1.06A | 5hwcA-5xb0A:16.1 | 5hwcA-5xb0A:31.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5IH0_A_ERYA404_1 (MACROLIDE2'-PHOSPHOTRANSFERASE II) |
5mux | 2-METHYLCITRATEDEHYDRATASE (Bacillussubtilis) | 4 / 6 | ASP A 92HIS A 104ILE A 88TYR A 203 | TLA A 501 ( 4.9A)TLA A 501 (-4.0A)NoneNone | 1.21A | 5ih0A-5muxA:undetectable | 5ih0A-5muxA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5IKT_B_TLFB601_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ujc | MMACHC-LIKE PROTEIN (Caenorhabditiselegans) | 3 / 3 | TYR A 122TYR A 241SER A 60 | NoneTLA A 301 (-4.5A)None | 0.99A | 5iktB-5ujcA:undetectable | 5iktB-5ujcA:19.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5KOX_A_RFPA502_1 (PENTACHLOROPHENOL4-MONOOXYGENASE) |
2c1l | RESTRICTIONENDONUCLEASE (Bacillusfirmus) | 5 / 12 | GLY A 130GLY A 110VAL A 120GLY A 50GLY A 49 | TLA A1363 ( 4.5A)NoneNoneNoneNone | 0.84A | 5koxA-2c1lA:undetectable | 5koxA-2c1lA:23.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5L5F_Y_BO2Y301_1 (PROTEASOME SUBUNITBETATYPE-8,PROTEASOMESUBUNIT BETA TYPE-5PROTEASOME SUBUNITBETATYPE-6,PROTEASOMESUBUNIT BETATYPE-1,PROTEASOMESUBUNIT BETATYPE-6,PROTEASOMESUBUNIT BETATYPE-1,PROTEASOMESUBUNIT BETA TYPE-6) |
5n6c | D-3-PHOSPHOGLYCERATEDEHYDROGENASE (Homosapiens) | 4 / 8 | THR A 98SER A 55ALA A 286SER A 287 | NoneTLA A 401 (-2.9A)TLA A 401 ( 3.2A)None | 1.09A | 5l5fY-5n6cA:undetectable5l5fZ-5n6cA:undetectable | 5l5fY-5n6cA:15.465l5fZ-5n6cA:16.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5N1T_W_CUW201_0 (COPC) |
5aho | 5' EXONUCLEASEAPOLLO (Homosapiens) | 3 / 3 | HIS A 99ASP A 145HIS A 276 | ZN A1321 ( 3.4A)NoneTLA A1319 ( 3.9A) | 0.90A | 5n1tW-5ahoA:undetectable | 5n1tW-5ahoA:19.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5NEK_B_AZMB302_1 (PEPTIDOGLYCANN-ACETYLGLUCOSAMINEDEACETYLASE) |
5aho | 5' EXONUCLEASEAPOLLO (Homosapiens) | 5 / 8 | ASP A 120HIS A 31HIS A 36ARG A 259HIS A 276 | ZN A1320 (-2.5A) ZN A1321 (-3.3A) ZN A1320 ( 3.4A)NoneTLA A1319 ( 3.9A) | 1.11A | 5nekB-5ahoA:undetectable | 5nekB-5ahoA:19.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5NEK_D_AZMD302_1 (PEPTIDOGLYCANN-ACETYLGLUCOSAMINEDEACETYLASE) |
5aho | 5' EXONUCLEASEAPOLLO (Homosapiens) | 5 / 8 | ASP A 120HIS A 31HIS A 36ARG A 259HIS A 276 | ZN A1320 (-2.5A) ZN A1321 (-3.3A) ZN A1320 ( 3.4A)NoneTLA A1319 ( 3.9A) | 1.10A | 5nekD-5ahoA:undetectable | 5nekD-5ahoA:19.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5NNA_C_BZMC301_0 (ISATIN HYDROLASE A) |
2cve | HYPOTHETICAL PROTEINTTHA1053 (Thermusthermophilus) | 5 / 12 | LEU A 104PRO A 73VAL A 90GLY A 49GLY A 71 | TLA A 192 (-4.5A)NoneNoneNoneNone | 0.93A | 5nnaC-2cveA:undetectable | 5nnaC-2cveA:23.02 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5NZW_A_9F2A1102_1 (DNA CROSS-LINKREPAIR 1A PROTEIN) |
5aho | 5' EXONUCLEASEAPOLLO (Homosapiens) | 6 / 10 | HIS A 31HIS A 33HIS A 36HIS A 99ASP A 120HIS A 276 | ZN A1321 (-3.3A) ZN A1321 ( 3.2A) ZN A1320 ( 3.4A) ZN A1321 ( 3.4A) ZN A1320 (-2.5A)TLA A1319 ( 3.9A) | 0.24A | 5nzwA-5ahoA:20.8 | 5nzwA-5ahoA:35.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5NZW_A_9F2A1102_1 (DNA CROSS-LINKREPAIR 1A PROTEIN) |
5aho | 5' EXONUCLEASEAPOLLO (Homosapiens) | 6 / 10 | HIS A 31HIS A 33HIS A 36HIS A 99ASP A 120THR A 257 | ZN A1321 (-3.3A) ZN A1321 ( 3.2A) ZN A1320 ( 3.4A) ZN A1321 ( 3.4A) ZN A1320 (-2.5A)TLA A1322 (-3.3A) | 0.66A | 5nzwA-5ahoA:20.8 | 5nzwA-5ahoA:35.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5O4Y_F_CCSF14_0 (PHE-MAA-ASN-PRO-HIS-LEU-SER-TRP-SER-TRP-9KK-9KK-ARG-CCS-GLY-NH2) |
3p1t | PUTATIVEHISTIDINOL-PHOSPHATEAMINOTRANSFERASE (Burkholderiapseudomallei) | 4 / 6 | PHE A 195SER A 196ARG A 205GLY A 203 | NoneNoneTLA A 343 ( 4.1A)None | 1.12A | 5o4yF-3p1tA:undetectable | 5o4yF-3p1tA:4.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ODI_G_ACTG702_0 (HETERODISULFIDEREDUCTASE, SUBUNIT A) |
2jfw | GLUTAMATE RACEMASE (Enterococcusfaecium) | 3 / 3 | GLY A 187THR A 121ASN A 78 | NoneTLA A1272 (-3.9A)TLA A1272 (-4.3A) | 0.68A | 5odiG-2jfwA:4.3 | 5odiG-2jfwA:19.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ODI_G_ACTG702_0 (HETERODISULFIDEREDUCTASE, SUBUNIT A) |
2jfw | GLUTAMATE RACEMASE (Enterococcusfaecium) | 3 / 3 | GLY A 187THR A 189ASN A 78 | NoneNoneTLA A1272 (-4.3A) | 0.53A | 5odiG-2jfwA:4.3 | 5odiG-2jfwA:19.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5WBV_A_SAMA402_1 (HISTONE-LYSINEN-METHYLTRANSFERASEKMT5B) |
4it1 | PUTATIVE GLUCARATEDEHYDRATASE (Pseudomonasfluorescens) | 3 / 3 | HIS A 320GLU A 246ASN A 223 | None MG A 501 (-2.8A)TLA A 502 (-3.7A) | 0.97A | 5wbvA-4it1A:undetectable | 5wbvA-4it1A:22.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5WBV_B_SAMB402_1 (HISTONE-LYSINEN-METHYLTRANSFERASEKMT5B) |
4it1 | PUTATIVE GLUCARATEDEHYDRATASE (Pseudomonasfluorescens) | 3 / 3 | HIS A 320GLU A 246ASN A 223 | None MG A 501 (-2.8A)TLA A 502 (-3.7A) | 0.97A | 5wbvB-4it1A:undetectable | 5wbvB-4it1A:22.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5Y2T_A_8LXA501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3dme | CONSERVED EXPORTEDPROTEIN (Bordetellapertussis) | 3 / 3 | SER A 350HIS A 52TYR A 248 | TLA A 999 ( 2.6A)TLA A 999 ( 3.7A)TLA A 999 (-4.7A) | 0.96A | 5y2tA-3dmeA:undetectable | 5y2tA-3dmeA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5Y9Y_A_ACTA412_0 (UNCHARACTERIZEDPROTEIN KDOO) |
2egz | 3-DEHYDROQUINATEDEHYDRATASE (Aquifexaeolicus) | 3 / 3 | ARG A 30PHE A 118ARG A 61 | TLA A4988 (-4.0A)NoneTLA A4988 (-3.1A) | 1.21A | 5y9yA-2egzA:undetectable | 5y9yA-2egzA:21.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5YSI_A_NCAA1001_0 (UBIQUITINATING/DEUBIQUITINATING ENZYMESDEA) |
3mwe | ATP-CITRATE SYNTHASE (Homosapiens) | 4 / 6 | ARG A 379GLY A 381SER A 343THR A 407 | TLA A 427 (-2.9A)NoneTLA A 427 ( 4.2A)None | 1.21A | 5ysiA-3mweA:undetectable | 5ysiA-3mweA:18.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ZJI_B_PQNB842_1 (PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A2) |
5o9h | C5A ANAPHYLATOXINCHEMOTACTIC RECEPTOR1 (Homosapiens) | 5 / 10 | ILE A 124TRP A 154ILE A 70ALA A 153ALA A 158 | 9P2 A 401 (-4.4A)NoneTLA A 402 (-3.3A)OLA A 404 ( 4.0A)OLA A 416 (-3.5A) | 1.43A | 5zjiB-5o9hA:2.1 | 5zjiB-5o9hA:23.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AG0_A_ACRA607_0 (ALPHA-AMYLASE) |
3g0o | 3-HYDROXYISOBUTYRATEDEHYDROGENASE (Salmonellaenterica) | 4 / 4 | ARG A 226SER A 286ASP A 285ASN A 225 | TLA A 401 (-2.9A)NoneNoneTLA A 401 ( 4.6A) | 1.12A | 6ag0A-3g0oA:1.2 | 6ag0A-3g0oA:16.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6APH_A_ADNA501_2 (ADENOSYLHOMOCYSTEINASE) |
3dme | CONSERVED EXPORTEDPROTEIN (Bordetellapertussis) | 4 / 5 | GLN A 86THR A 354HIS A 52LEU A 246 | NoneFAD A 500 (-3.8A)TLA A 999 ( 3.7A)None | 1.21A | 6aphA-3dmeA:undetectable | 6aphA-3dmeA:22.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B5V_A_ECLA1001_1 (TRANSIENT RECEPTORPOTENTIAL CATIONCHANNEL SUBFAMILY VMEMBER 5) |
5unc | PHOSPHOENOLPYRUVATEPHOSPHOMUTASE (Streptomycesplatensis) | 4 / 7 | ILE A 201LEU A 200ILE A 234ALA A 250 | NoneNoneNoneTLA A 401 (-3.5A) | 0.86A | 6b5vA-5uncA:undetectable6b5vC-5uncA:undetectable | 6b5vA-5uncA:14.646b5vC-5uncA:14.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B5V_C_ECLC1001_1 (TRANSIENT RECEPTORPOTENTIAL CATIONCHANNEL SUBFAMILY VMEMBER 5) |
5unc | PHOSPHOENOLPYRUVATEPHOSPHOMUTASE (Streptomycesplatensis) | 4 / 7 | ILE A 201LEU A 200ILE A 234ALA A 250 | NoneNoneNoneTLA A 401 (-3.5A) | 0.86A | 6b5vC-5uncA:undetectable6b5vD-5uncA:undetectable | 6b5vC-5uncA:14.646b5vD-5uncA:14.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B5V_D_ECLD1001_1 (TRANSIENT RECEPTORPOTENTIAL CATIONCHANNEL SUBFAMILY VMEMBER 5) |
5unc | PHOSPHOENOLPYRUVATEPHOSPHOMUTASE (Streptomycesplatensis) | 4 / 7 | ALA A 250ILE A 201LEU A 200ILE A 234 | TLA A 401 (-3.5A)NoneNoneNone | 0.86A | 6b5vB-5uncA:undetectable6b5vD-5uncA:undetectable | 6b5vB-5uncA:14.646b5vD-5uncA:14.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6CE2_B_SVRB202_1 () |
3i16 | ALUMINUM RESISTANCEPROTEIN (Clostridiumnovyi) | 4 / 8 | LEU A 107LEU A 103GLY A 122TYR A 125 | NoneNoneNoneTLA A 427 (-4.5A) | 0.95A | 6ce2A-3i16A:1.8 | 6ce2A-3i16A:16.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6DWN_A_AQ4A602_0 (CYTOCHROME P450 1A1) |
1oht | CG14704 PROTEIN (Drosophilamelanogaster) | 5 / 12 | SER A 108ASN A 179PHE A 175GLY A 151PHE A 166 | NoneTLA A1188 (-3.2A)NoneNoneNone | 1.35A | 6dwnA-1ohtA:undetectable | 6dwnA-1ohtA:15.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6FGD_A_ACTA826_0 (GEPHYRIN) |
3os7 | GALACTOSEMUTAROTASE-LIKEPROTEIN (Clostridiumacetobutylicum) | 3 / 3 | HIS A 108ARG A 81ILE A 107 | TLA A 401 (-3.9A)TLA A 401 ( 4.1A)None | 0.88A | 6fgdA-3os7A:undetectable | 6fgdA-3os7A:21.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6GBN_B_ADNB501_2 (-) |
3dme | CONSERVED EXPORTEDPROTEIN (Bordetellapertussis) | 4 / 5 | GLN A 86THR A 354HIS A 52LEU A 246 | NoneFAD A 500 (-3.8A)TLA A 999 ( 3.7A)None | 1.22A | 6gbnB-3dmeA:undetectable | 6gbnB-3dmeA:23.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6GIQ_T_PCFT101_0 (CYTOCHROME B-C1COMPLEX SUBUNIT 1,MITOCHONDRIALCYTOCHROME B-C1COMPLEX SUBUNIT 9CYTOCHROME B-C1COMPLEX SUBUNITRIESKE,MITOCHONDRIAL) |
6frl | TRYPTOPHANHALOGENASESUPERFAMILY (Brevundimonassp.BAL3) | 4 / 8 | ASP A 208GLY A 223SER A 341VAL A 15 | NoneTLA A 601 (-3.3A)NoneNone | 1.11A | 6giqL-6frlA:undetectable6giqP-6frlA:undetectable6giqT-6frlA:undetectable | 6giqL-6frlA:undetectable6giqP-6frlA:undetectable6giqT-6frlA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6GTQ_B_ACTB207_0 (DUF1778DOMAIN-CONTAININGPROTEINN-ACETYLTRANSFERASE) |
5b19 | ASPARTATE RACEMASE (Picrophilustorridus) | 4 / 6 | THR A 16CYH A 83GLY A 10ARG A 49 | NoneTLA A 301 (-3.1A)NoneTLA A 301 (-3.8A) | 1.28A | 6gtqB-5b19A:undetectable6gtqD-5b19A:undetectable | 6gtqB-5b19A:20.096gtqD-5b19A:13.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6HQB_B_PQNB2002_0 (PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A2) |
5o9h | C5A ANAPHYLATOXINCHEMOTACTIC RECEPTOR1 (Homosapiens) | 5 / 9 | TRP A 161ILE A 70ALA A 153LEU A 156ALA A 160 | NoneTLA A 402 (-3.3A)OLA A 404 ( 4.0A)9P2 A 401 (-3.9A)9P2 A 401 ( 3.9A) | 1.46A | 6hqbB-5o9hA:1.2 | 6hqbB-5o9hA:22.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6HU9_S_PCFS603_0 (CYTOCHROME B-C1COMPLEX SUBUNIT 8CYTOCHROME C OXIDASEPOLYPEPTIDE 5A,MITOCHONDRIAL) |
5xvh | 6-PHOSPHOGLUCONATEDEHYDROGENASE,NAD-BINDING PROTEIN (Pyrobaculumcalidifontis) | 4 / 7 | GLN A 124GLY A 230PHE A 231HIS A 278 | NoneNoneTLA A 301 ( 4.1A)None | 1.02A | 6hu9S-5xvhA:undetectable6hu9q-5xvhA:undetectable | 6hu9S-5xvhA:undetectable6hu9q-5xvhA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6MKE_A_FK5A201_0 (PEPTIDYLPROLYLISOMERASE) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 8 / 12 | TYR A 147ASP A 158VAL A 171ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 0.65A | 6mkeA-5xb0A:16.76mkeD-5xb0A:16.2 | 6mkeA-5xb0A:18.386mkeD-5xb0A:18.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6MKE_A_FK5A201_0 (PEPTIDYLPROLYLISOMERASE) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 7 / 12 | TYR A 147PHE A 166ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 ( 4.6A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 1.05A | 6mkeA-5xb0A:16.76mkeD-5xb0A:16.2 | 6mkeA-5xb0A:18.386mkeD-5xb0A:18.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6MKE_B_FK5B201_0 (PEPTIDYLPROLYLISOMERASE) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 6 / 12 | PHE A 166ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.6A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 1.11A | 6mkeB-5xb0A:16.76mkeC-5xb0A:16.4 | 6mkeB-5xb0A:18.386mkeC-5xb0A:18.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6MKE_B_FK5B201_0 (PEPTIDYLPROLYLISOMERASE) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 8 / 12 | TYR A 147ASP A 158VAL A 171ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 0.64A | 6mkeB-5xb0A:16.76mkeC-5xb0A:16.4 | 6mkeB-5xb0A:18.386mkeC-5xb0A:18.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6MKE_C_FK5C201_1 (PEPTIDYLPROLYLISOMERASE) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 7 / 10 | PHE A 166VAL A 171ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.6A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 1.01A | 6mkeC-5xb0A:16.4 | 6mkeC-5xb0A:18.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6MKE_C_FK5C201_1 (PEPTIDYLPROLYLISOMERASE) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 8 / 10 | TYR A 147ASP A 158VAL A 171ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 0.69A | 6mkeC-5xb0A:16.4 | 6mkeC-5xb0A:18.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6MKE_D_FK5D201_1 (PEPTIDYLPROLYLISOMERASE) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 7 / 10 | PHE A 166VAL A 171ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.6A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 1.02A | 6mkeD-5xb0A:16.2 | 6mkeD-5xb0A:18.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6MKE_D_FK5D201_1 (PEPTIDYLPROLYLISOMERASE) |
5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringaegroupgenomosp.3) | 8 / 10 | TYR A 147ASP A 158VAL A 171ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 0.69A | 6mkeD-5xb0A:16.2 | 6mkeD-5xb0A:18.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6N91_A_DCFA401_0 (ADENOSINE DEAMINASE) |
4mrq | PHOSPHOMANNOMUTASE/PHOSPHOGLUCOMUTASE (Pseudomonasaeruginosa) | 5 / 12 | ASP A 18SER A 309HIS A 329ASP A 242ASP A 244 | TLA A 502 ( 4.8A)NoneTLA A 502 (-4.0A) ZN A 501 ( 2.3A) ZN A 501 ( 2.5A) | 1.27A | 6n91A-4mrqA:undetectable | 6n91A-4mrqA:9.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6N91_B_DCFB401_0 (ADENOSINE DEAMINASE) |
4mrq | PHOSPHOMANNOMUTASE/PHOSPHOGLUCOMUTASE (Pseudomonasaeruginosa) | 5 / 12 | ASP A 18SER A 309HIS A 329ASP A 242ASP A 244 | TLA A 502 ( 4.8A)NoneTLA A 502 (-4.0A) ZN A 501 ( 2.3A) ZN A 501 ( 2.5A) | 1.26A | 6n91B-4mrqA:undetectable | 6n91B-4mrqA:9.91 |